Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 49
Encontrada(s) 1 página(s)

Docta Complutense
Publicación Artículo científico (JournalArticle)

The challenge of managing threatened invasive species at a continental scale

  • Baquero Noriega, Rocío Aranzazu
  • Oficialdegui, Francisco Javier
  • Ayllón Fernández, Daniel
  • Gómez Nicola, María Gracia
The European Union's (EU) environmental legislation establishes common measures to prevent the entry and spread of invasive non-native species and to minimize their impacts. However, species that are native to at least one member state but non-native and potentially invasive in others (NPIS) are in limbo because they are neither legally regulated at the EU level nor in most member states. We used the Communication and Information Resource Centre for Administrations, Businesses and Citizens (CIRCABC) raw data on NPIS (317 taxa) to analyze their distribution across the EU and identify which biogeographical regions are the main sources of invasions. We additionally evaluated the conservation challenge posed by NPIS that are threatened within their native ranges. We performed a pairwise analysis summarizing the number of species that are native to a given member state but non-native to another and vice versa. Although distribution patterns of NPIS varied across taxa groups, overall, southern and central EU countries were both donors and recipients of NPIS. Eastern countries were mainly a source, and western and northern countries mostly received NPIS. Around 27% of NPIS were threatened in some of their EU native ranges, which is a challenge for conservation and management because some of them have serious negative effects on European biodiversity, but hitherto remain outside the scope of the EU regulation of invasive non-native species. This highlights an unresolved paradox because efforts to manage species as invasive conflict with efforts to protect them as threatened within the same territory.
Docta Complutense
Publicación Artículo científico (JournalArticle)

CB1 receptors in NG2 cells mediate cannabinoid-evoked functional myelin regeneration

  • Sánchez De La Torre, Aníbal
  • Ezquerro Herce, Sara
  • Huerga Gómez, Alba
  • Sánchez Martín, Ester
  • Chara, Juan Carlos
  • Matute, Carlos
  • Monory, Krisztina
  • Mato, Susana
  • Lutz, Beat
  • Guzmán Pastor, Manuel
  • Aguado Sánchez, Tania
  • Palazuelos Diego, Javier
Defects in myelin homeostasis have been reported in many neuropathological conditions. Cannabinoid compounds have been shown to efficiently promote myelin regeneration in animal models of demyelination. However, it is still unknown whether this action relies mostly on a cell autonomous effect on oligodendroglial-lineage-NG2 cells. By using conditional genetic mouse models, here we found that cannabinoid CB1 receptors located on NG2 cells are required for oligodendroglial differentiation and myelin regeneration after demyelination. Selective CB1 receptor gene depletion in NG2 cells following toxin-induced demyelination disrupted oligodendrocyte regeneration and functional remyelination and exacerbated axonal damage. These deficits were rescued by pharmacological blockade of the RhoA/ROCK/Cofilin pathway. Conversely, tetrahydrocannabinol administration promoted oligodendrocyte regeneration and functional remyelination in wild-type but not Ng2-CB1-deficient mice. Overall, this study identifies CB1 receptors as essential modulators of remyelination and support the therapeutic potential of cannabinoids for promoting remyelination in neurological disorders.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

BRCA1 loss activates cathepsin L-mediated degradation of 53BP1 in breast cancer cells

  • Grotsky, David A.
  • Gonzalez-Suarez, Ignacio
  • Novell, Anna|||0000-0001-6619-8062
  • Neumann, Martin A.
  • Yaddanapudi, Sree C. S.
  • Croke, Monica R.
  • Martinez-Alonso, Montserrat|||0000-0003-1504-8552
  • Redwood, Abena B.
  • Ortega-Martinez, Sylvia
  • Feng, Zhihui
  • Lerma Puertas, Enrique|||0000-0001-7908-2747
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Zhang, Junran
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • Dusso, Ariadna S.
  • Gonzalo, Susana
Loss of 53BP1 rescues BRCA1 deficiency and is associated with BRCA1-deficient and triple-negative breast cancers (TNBC) and with resistance to genotoxic drugs. The mechanisms responsible for decreased 53BP1 transcript and protein levels in tumors remain unknown. Here, we demonstrate that BRCA1 loss activates cathepsin L (CTSL)-mediated degradation of 53BP1. Activation of this pathway rescued homologous recombination repair and allowed BRCA1-deficient cells to bypass growth arrest. Importantly, depletion or inhibition of CTSL with vitamin D or specific inhibitors stabilized 53BP1 and increased genomic instability in response to radiation and poly(adenosine diphosphate-ribose) polymerase inhibitors, compromising proliferation. Analysis of human breast tumors identified nuclear CTSL as a positive biomarker for TNBC, which correlated inversely with 53BP1. Importantly, nuclear levels of CTSL, vitamin D receptor, and 53BP1 emerged as a novel triple biomarker signature for stratification of patients with BRCA1-mutated tumors and TNBC, with potential predictive valuefor drug response. We identify here a novel pathway with prospective relevance for diagnosis and customization of breast cancer therapy. © 2013 Grotsky et al.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

High frequency of CRB1 mutations as cause of Early-Onset Retinal Dystrophies in the Spanish population

  • Corton, Marta|||0000-0003-0087-1626
  • Tatu, Sorina D.
  • Avila-Fernandez, Almudena
  • Vallespín, Elena|||0000-0002-8080-8629
  • Tapias, Ignacio
  • Cantalapiedra, Diego
  • Blanco-Kelly, Fiona|||0000-0003-0052-5651
  • Riveiro-Alvarez, Rosa
  • Bernal, Sara|||0000-0003-4427-0574
  • García-Sandoval, Blanca
  • Baiget Bastús, Montserrat
  • Ayuso, Carmen|||0000-0002-9606-6957
Background: CRB1 mutations are reported as cause of severe congenital and early-onset retinal dystrophies (EORD) with different phenotypic manifestations, including Leber congenital amaurosis (LCA), retinitis pigmentosa (RP) and cone-rod dystrophies. Comprehensive mutational scanning of the whole gene has been only performed in few cohorts, mainly in LCA patients. Here, we aimed investigating the real prevalence of CRB1 mutations in the Spanish population by extensive screening of CRB1 mutations in a large cohort of LCA and EORP cases. Methods. This report integrates data from previous studies on CRB1 defects in our Spanish cohort of LCA and early-onset RP (EORP) with new findings from a comprehensive mutational screening of the whole gene. The molecular tools used include mutation genotyping arrays, whole-genome homozygosity mapping, an optimized high-resolution melting (HRM) analysis and Sanger sequencing. Results: A large clinically well-characterized cohort of 404 Spanish cases was studied, 114 of which suffered from LCA and 290 from EORP. This study reveals that 11% of Spanish patients carried mutations in CRB1, ranging from 9% of EORP to 14% of LCA cases. More than three quarters of the mutations identified herein have been first described in this Spanish cohort, 13 of them are unreported new variants and 13 had been previously reported in our previous studies. Conclusions: This work provides a wide spectrum of CRB1 mutations in the Spanish EORD patients and evidences the major role of CRB1 as causal gene in the Spanish EORP patients. It is noteworthy that a high rate of private mutations only described in our cohort has been found so far. To our knowledge, this study represents the most complete mutational screening of CRB1 in a Spanish LCA and EORP cohort, allowing us to establish gene-specific frequencies and to provide a wide spectrum of CRB1 mutations in the Spanish population. © 2013 Corton et al.; licensee BioMed Central Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

High RAB25 expression is associated with good clinical outcome in patients with locally advanced head and neck squamous cell carcinoma

  • Téllez-Gabriel, Marta
  • Arroyo Solera, Irene|||0000-0003-0425-1483
  • León i Vintró, Xavier|||0000-0001-6286-630X
  • Gallardo, Alberto|||0000-0002-2514-2027
  • López, Montserrat
  • Céspedes, María Virtudes|||0000-0003-2956-5833
  • Casanova Rigat, Isolda|||0000-0002-1196-4724
  • López Pousa, Antonio|||0000-0003-1066-3951
  • Quer, Miquel|||0000-0003-2563-6729
  • Mangues, Ma Antonia|||0000-0002-1438-8515
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
  • Mangues, Ramon|||0000-0003-2661-9525
  • Pavón, Miguel A.
Currently there are no molecular markers able to predict clinical outcome in locally advanced head and neck squamous cell carcinoma (HNSCC). In a previous microarray study, RAB25 was identified as a potential prognostic marker. The aim of this study was to analyze the association between RAB25 expression and clinical outcome in patients with locally advanced HNSCC treated with standard therapy. In a retrospective immunohistochemical study (n = 97), we observed that RAB25-negative tumors had lower survival (log-rank, P = 0.01) than patients bearing positive tumors. In an independent prospective mRNA study (n = 117), low RAB25 mRNA expression was associated with poor prognosis. Using classification and regression tree analysis (CART) we established two groups of patients according to their RAB25 mRNA level and their risk of death. Low mRNA level was associated with poor local recurrence-free (log-rank, P = 0.005), progression-free (log-rank, P = 0.002) and cancer-specific (log-rank, P < 0.001) survival. Multivariate Cox model analysis showed that low expression of RAB25 was an independent poor prognostic factor for survival (hazard ratio: 3.84, 95% confidence interval: 1.93-7.62, P < 0.001). Patients whose tumors showed high RAB25 expression had a low probability of death after treatment. We also found lower RAB25 expression in tumors than in normal tissue (Mann-Whitney U, P < 0.001). Moreover, overexpression of RAB25 in the UM-SCC-74B HNSCC cell line increased cisplatin sensitivity, and reduced cell migration and invasion. Our findings support a tumor suppressor role for RAB25 in HNSCC and its potential use to identify locally advanced patients with a high probability of survival after genotoxic treatment. © 2013 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Development and Independent Validation of a Prognostic Gene Expression Signature Based on RB1, PTEN, and TP53 in Metastatic Hormone-sensitive Prostate Cancer Patients

  • Jiménez, Natalia|||0000-0002-7057-0426
  • Garcia de Herreros, Marta
  • Reig, Oscar|||0000-0003-1166-6943
  • Marín Aguilera, Mercedes
  • Aversa, Caterina
  • Ferrer-Mileo, Laura
  • García-Esteve, Samuel|||0000-0002-7680-2048
  • Rodríguez-Carunchio, Leonardo|||0000-0002-7019-554X
  • Trias, Isabel|||0000-0001-9841-4380
  • Font, Albert|||0000-0003-3908-1111
  • Rodriguez-Vida, Alejo|||0000-0002-7304-6857
  • Climent, Miguel Ángel|||0000-0001-7523-0212
  • Cros Costa, Sara|||0000-0001-8279-784X
  • Chirivella, Isabel|||0000-0002-0733-3276
  • Domènech, Montserrat|||0000-0003-3973-0986
  • Figols, Mariona
  • Carles, Joan|||0000-0002-9983-5934
  • Suárez, Cristina|||0000-0002-0502-5528
  • Herrero Rivera, Daniel
  • Gonzalez-Billalabeitia, Enrique|||0000-0003-3143-3143
  • Cívico, Claudia
  • Sala-González, Núria
  • Ruiz de Porras, Vicenç|||0000-0002-4352-1784
  • Ribal, María J.|||0000-0001-8142-5382
  • Prat, Aleix|||0000-0003-2377-540X
  • Mellado, Begoña|||0000-0002-8088-5966
BACKGROUND: Androgen deprivation therapy (ADT) with docetaxel (D) and/or antiandrogen receptor therapies (ARTs) are the standard therapies in metastatic hormone-sensitive prostate cancer (mHSPC). Alterations in the tumor suppressor genes (TSGs) RB1, PTEN, and TP53 are associated with an aggressive evolution and treatment resistance in castration-resistant prostate cancer (CRPC). OBJECTIVE: To study the clinical implications of TSG mRNA expression in mHSPC patients. DESIGN, SETTING, AND PARTICIPANTS: This is a multicenter retrospective biomarker study in mHSPC patients. TSGlow status was defined when two or more out of the three TSGs presented low RNA expression by nCounter in formalin-fixed paraffin-embedded samples and TSGwt for the remaining cases. The microarray data from the CHAARTED trial were analyzed as an independent validation cohort. OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS: Molecular data were correlated with CRPC-free survival (CRPC-FS) and overall survival (OS) by the Kaplan-Meier method and multivariate Cox analysis. RESULTS AND LIMITATIONS: A total of 226 patients were included, of whom 218 were eligible: 93 were treated with ADT and 125 with ADT + D; 75.7% presented de novo stage IV and 67.9% high-volume disease. TSGlow (19.2%) was independently correlated with shorter CRPC-FS (hazard ratio [HR] 1.8, p = 0.002) and OS (HR 2, p = 0.002). In the CHAARTED trial, TSGlow was independently correlated with lower CRPC-FS (HR 2.2, p = 0.02); no differences in clinical outcomes according to treatment were observed in TSGlow patients, while a significant benefit was observed for ADT + D in the TSGwt group for CRPC-FS (HR 0.4, p < 0.001) and OS (HR 0.4, p = 0.001). However, no interaction was observed between TSG signature and treatment in either series. Study limitations are the retrospective design, small sample size, and lack of inclusion of patients treated with ADT + ART. CONCLUSIONS: TSGlow expression correlates with adverse outcomes in patients with mHSPC. The investigation of new therapeutic strategies in these patients is warranted. PATIENT SUMMARY: The low RNA expression of tumor suppressor genes in the tumors is correlated with adverse outcomes in patients with metastatic hormone-sensitive prostate cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Cabezas en un tupperware, identidades, pertenencias y lenguajes en la narrativa migrante de "Casi nada que ponerte" (2023) de Lucía Lijtmaer, Caps en un tupperware, Heads in a tupperware

  • Romero Morales, Yasmina|||0000-0003-0255-5782
Desde una perspectiva feminista y migrante, este artículo examina la obra Casi nada que ponerte (2023) de Lucía Lijtmaer, abordando tres dimensiones clave: la fragmentación identitaria, las pertenencias y los lenguajes intermedios. A través de una hibridación cultural que Lijtmaer describe como una "dualidad esquizofrénica" (2023: 111), su narrativa articula una crítica social incisiva que desafía categorías hegemónicas y expande los límites de la literatura migrante. El análisis interdisciplinario conecta teorías de Bhabha, Braidotti, Bourriaud y Appadurai, situando la obra de Lijtmaer en un marco transnacional que dialoga con la movilidad, el desarraigo y las dinámicas culturales contemporáneas., Des d'una perspectiva feminista i migrant, aquest article examina l'obra Casi nada que ponerte (2023) de Lucía Lijtmaer, abordant tres dimensions clau: la fragmentació identitària, les pertinences i els llenguatges intermedis. Mitjançant una hibridació cultural que Lijtmaer descriu com una "dualitat esquizofrènica" (2023: 111), la seva narrativa articula una crítica social incisiva que desafia categories hegemòniques i expandeix els límits de la literatura migrant. L'anàlisi interdisciplinari connecta teories de Bhabha, Braidotti, Bourriaud i Appadurai, situant l'obra de Lijtmaer en un marc transnacional que dialoga amb la mobilitat, el desarrelament i les dinàmiques culturals contemporànies., From a feminist and migrant perspective, this article examines Casi nada que ponerte (2023) by Lucía Lijtmaer, focusing on three key dimensions: identity fragmentation, belonging, and hybrid languages. Through a cultural hybridity that Lijtmaer describes as a "schizophrenic duality" (2023: 111), her narrative delivers incisive social criticism, challenging hegemonic categories and expanding the boundaries of migrant literature. The interdisciplinary analysis draws on theories by Bhabha, Braidotti, Bourriaud, and Appadurai, situating Lijtmaer's work within a transnational framework that engages with mobility, displacement, and contemporary cultural dynamics, Des d'una perspectiva feminista i migrant, aquest article examina l'obra Casi nada que ponerte (2023) de Lucía Lijtmaer, abordant tres dimensions clau: la fragmentació identitària, les pertinences i els llenguatges intermedis. Mitjançant una hibridació cultural que Lijtmaer descriu com una "dualitat esquizofrènica" (2023: 111), la seva narrativa articula una crítica social incisiva que desafia categories hegemòniques i expandeix els límits de la literatura migrant. L'anàlisi interdisciplinari connecta teories de Bhabha, Braidotti, Bourriaud i Appadurai, situant l'obra de Lijtmaer en un marc transnacional que dialoga amb la mobilitat, el desarrelament i les dinàmiques culturals contemporànies.
Dipòsit Digital de Documents de la UAB
Publicación Capítulo o parte de un libro (BookPart)

Arnau de Vilanova, «autor» problemàtic. Notes a propòsit de dues obres dels còdexs Praed. 58 i 121 de la Universitätsbibliothek de Frankfurt am Main

  • Mensa i Valls, Jaume|||0000-0002-3750-1226
Aquest article presenta breument dues obres conservades en dos còdexs de la Universitätsbibliothek de Frankfurt am Main: un Regiment de sanitat atribuït a Arnult von Mumpelyr i l'Alphabetum catholicorum d'Arnau de Vilanova. Arran d'aquestes obres, l'autor planteja dos problemes relatius a l'autoria de les obres d'Arnau o a ell atribuïdes: la simulació (un copista atribueix una obra mèdica o relacionada amb la medicina a un metge famós: Arnau de Vilanova); i la dissimulació (un copista evita de donar el nom d'Arnau, perquè algunes de les seves obres teològiques foren condemandes per la sentència de Tarragona de 1316)., This paper briefly presents two works preserved in two manuscripts of the Universitätsbibliothek Frankfurt am Main, a Regiment de sanitat attributed to Arnult von Mumpelyr and Alphabetum catholicorum of Arnau de Vilanova. Following these works, the author raises two problems concerning the authorship of Arnau de Vilanova's works or works which are attributed to him: simulation (a copyist attributes a work related to medical care to a famous doctor: Arnau de Vilanova) and dissimulation (a copyist avoids giving the name of Arnau, because some of his theological works were condemned by the sentence passed in Tarragona in 1316).
Repisalud
Publicación Artículo científico (JournalArticle)

Quantitative HDL Proteomics Identifies Peroxiredoxin-6 as a Biomarker of Human Abdominal Aortic Aneurysm

  • Burillo, Elena
  • Jorge, Inmaculada
  • Martinez-Lopez, Diego
  • Camafeita, Emilio
  • Miguel Blanco-Colio, Luis
  • Trevisan-Herraz, Marco
  • Ezkurdia, Iakes
  • Egido, Jesus
  • Michel, Jean-Baptiste
  • Meilhac, Olivier
  • Vazquez, Jesus
  • Luis Martin-Ventura, Jose
High-density lipoproteins (HDLs) are complex protein and lipid assemblies whose composition is known to change in diverse pathological situations. Analysis of the HDL proteome can thus provide insight into the main mechanisms underlying abdominal aortic aneurysm (AAA) and potentially detect novel systemic biomarkers. We performed a multiplexed quantitative proteomics analysis of HDLs isolated from plasma of AAA patients (N = 14) and control study participants (N = 7). Validation was performed by western-blot (HDL), immunohistochemistry (tissue), and ELISA (plasma). HDL from AAA patients showed elevated expression of peroxiredoxin-6 (PRDX6), HLA class I histocompatibility antigen (HLA-I), retinol-binding protein 4, and paraoxonase/arylesterase 1 (PON1), whereas alpha-2 macroglobulin and C4b-binding protein were decreased. The main pathways associated with HDL alterations in AAA were oxidative stress and immune-inflammatory responses. In AAA tissue, PRDX6 colocalized with neutrophils, vascular smooth muscle cells, and lipid oxidation. Moreover, plasma PRDX6 was higher in AAA (N = 47) than in controls (N = 27), reflecting increased systemic oxidative stress. Finally, a positive correlation was recorded between PRDX6 and AAA diameter. The analysis of the HDL proteome demonstrates that redox imbalance is a major mechanism in AAA, identifying the antioxidant PRDX6 as a novel systemic biomarker of AAA.
Repisalud
Publicación Artículo científico (JournalArticle)

APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm

  • Martínez-López, Diego
  • Camafeita, Emilio
  • Cedó, Lídia
  • Roldan-Montero, Raquel
  • Jorge, Inmaculada
  • Garcia-Marques, Fernando
  • Gomez-Serrano, Maria
  • Bonzon-Kulichenko, Elena
  • Blanco-Vaca, Francisco
  • Blanco-Colio, Luis Miguel
  • Michel, Jean-Baptiste
  • Escola-Gil, Joan Carles
  • Vazquez, Jesus
  • Martin-Ventura, Jose Luis
BACKGROUND: High-density lipoproteins (HDL) are a complex mixture of lipids and proteins with vasculoprotective properties. However, HDL components could suffer post-translational modifications (PTMs) under pathological conditions, leading to dysfunctional HDL. We studied whether HDL are modified in abdominal aortic aneurysm (AAA) and the effect on HDL functionality. METHODS: HDL were isolated by ultracentrifugation from AAA tissue (HDL-T) and from plasma of healthy volunteers and then incubated with AAA tissue-conditioned medium (HDL-AAA CM). PTMs from these particles were characterized using Comet-PTM. The ability of HDL-AAA CM for promoting cholesterol efflux was determined ex vivo and in vivo by using J774A.1 [3H]cholesterol-labeled mouse macrophages and after injecting [3H]cholesterol-labeled mouse macrophages and HDL into the peritoneal cavity of wild-type C57BL/6 mice, respectively. Trp50 and Trp108 oxidized forms of APOA1 in HDL incubated with conditioned-medium of activated neutrophils and in plasma of AAA patients and controls were measured by targeted parallel reaction monitoring. FINDINGS: Oxidation was the most prevalent PTM in apolipoproteins, particularly in APOA1. Trp50 and Trp108 in APOA1 were the residues most clearly affected by oxidation in HDL-T and in HDL-AAA CM, when compared to their controls. In addition, cholesterol efflux was decreased in macrophages incubated with HDL-AAA CM in vitro and a decreased macrophage-to-serum reverse cholesterol transport was also observed in mice injected with HDL-AAA CM. Finally, both oxidized Trp50 and Trp108 forms of APOA1 were increased in HDL incubated with conditioned-medium of activated neutrophils and in plasma of AAA patients in relation to controls. INTERPRETATION: Oxidative modifications of HDL present in AAA tissue and plasma were closely associated with the loss of vasculoprotective properties of HDL in AAA. FUND: MINECO, ISCiii-FEDER, CIBERDEM, CIBERCV and LA CAIXA.
Repisalud
Publicación Artículo científico (JournalArticle)

Aberrant Epstein-Barr virus antibody patterns and chronic lymphocytic leukemia in a Spanish multicentric case-control study

  • Casabonne, Delphine
  • Benavente, Yolanda
  • Robles, Claudia
  • Costas, Laura
  • Alonso, Esther
  • Gonzalez-Barca, Eva
  • Tardón, Adonina
  • Dierssen-Sotos, Trinidad
  • Vázquez, Eva Gimeno
  • Aymerich, Marta
  • Campo, Elias
  • Castaño-Vinyals, Gemma
  • Aragones, Nuria
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Juwana, Hedy
  • Middeldorp, Jaap
  • de Sanjose, Silvia
BACKGROUND: Epstein-Barr virus (EBV)-related malignancies harbour distinct serological responses to EBV antigens. We hypothesized that EBV serological patterns can be useful to identify different stages of chronic lymphocytic leukemia. METHODS: Information on 150 cases with chronic lymphocytic leukemia and 157 frequency-matched (by age, sex and region) population-based controls from a Spanish multicentre case-control study was obtained. EBV immunoglobulin G serostatus was evaluated through a peptide-based ELISA and further by immunoblot analysis to EBV early antigens (EA), nuclear antigen (EBNA1), VCA-p18, VCA-p40 and Zebra. Two independent individuals categorized the serological patterns of the western blot analysis. Patients with very high response and diversity in EBV-specific polypeptides, in particular with clear responses to EA-associated proteins, were categorized as having an abnormal reactive pattern (ab_EBV). Adjusted odds ratios (OR) and 95% confidence interval (CI) were estimated using logistic regression models. RESULTS: Almost all subjects were EBV-IgG positive (>95% of cases and controls) whereas ab_EBV patterns were detected in 23% of cases (N = 34) and 11% of controls (N = 17; OR: 2.44, 95% CI, 1.29 to 4.62; P = 0.006), particularly in intermediate/high risk patients. Although based on small numbers, the association was modified by smoking with a gradual reduction of ab_EBV-related OR for all Rai stages from never smokers to current smokers. CONCLUSIONS: Highly distinct EBV antibody diversity patterns revealed by immunoblot analysis were detected in cases compared to controls, detectable at very early stages of the disease and particularly among non smokers. This study provides further evidence of an abnormal immunological response against EBV in patients with chronic lymphocytic leukemia.
Repisalud
Publicación Artículo científico (JournalArticle)

Risk Model for Prostate Cancer Using Environmental and Genetic Factors in the Spanish Multi-Case-Control (MCC) Study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Fernandez-Navarro, Pablo L
  • Palazuelos, Camilo
  • Moreno, Victor
  • Aragones, Nuria
  • Castaño-Vinyals, Gemma
  • Jimenez-Moleon, Jose J.
  • Ruiz-Cerdá, Jose Luis
  • Perez-Gomez, Beatriz
  • Ruiz-Dominguez, José Manuel
  • Molero, Jessica Alonso
  • Pollan-Santamaria, Marina
  • Kogevinas, Manolis
  • Llorca, Javier
Prostate cancer (PCa) is the second most common cancer among men worldwide. Its etiology remains largely unknown compared to other common cancers. We have developed a risk stratification model combining environmental factors with family history and genetic susceptibility. 818 PCa cases and 1,006 healthy controls were compared. Subjects were interviewed on major lifestyle factors and family history. Fifty-six PCa susceptibility SNPs were genotyped. Risk models based on logistic regression were developed to combine environmental factors, family history and a genetic risk score. In the whole model, compared with subjects with low risk (reference category, decile 1), those carrying an intermediate risk (decile 5) had a 265% increase in PCa risk (OR = 3.65, 95% CI 2.26 to 5.91). The genetic risk score had an area under the ROC curve (AUROC) of 0.66 (95% CI 0.63 to 0.68). When adding the environmental score and family history to the genetic risk score, the AUROC increased by 0.05, reaching 0.71 (95% CI 0.69 to 0.74). Genetic susceptibility has a stronger risk value of the prediction that modifiable risk factors. While the added value of each SNP is small, the combination of 56 SNPs adds to the predictive ability of the risk model.
Repisalud
Publicación Artículo científico (JournalArticle)

Label-free proteomic analysis of red blood cell membrane fractions from abdominal aortic aneurysm patients

  • Martinez-Pinna, Roxana
  • Burillo, Elena
  • Madrigal-Matute, Julio
  • Lopez, Juan Antonio
  • Camafeita, Emilio
  • Torres-Fonseca, Monica Maria
  • Llamas-Granda, Patricia
  • Egido, Jesus
  • Michel, Jean-Baptiste
  • Blanco-Colio, Luis Miguel
  • Martin-Ventura, Jose Luis
PURPOSE: To test whether red blood cell (RBC) membrane composition is modified in abdominal aortic aneurysms (AAA) patients. EXPERIMENTAL DESIGN: RBC membrane extracts from AAA patients (aortic diameter >3 cm, n = 7) and control subjects (n = 4) were analyzed by a label-free quantitative MS-based strategy, using spectral count data. Additional validation was performed by western-blot. RESULTS: Data analysis based on spectral count from MS/MS-based experiments provided us a signature of 39 proteins differentially expressed in RBC membranes between AAA and controls (changes equal/over 1.515-fold; p-values equal/lower 0.05). MS data revealed altered levels of structural membrane proteins (e.g. spectrins and ankyrin), components of the degradation machinery (proteasome subunits), and oxidative stress related proteins (e.g. catalase and peroxiredoxin-2) among others. Decreased catalase and peroxiredoxin-2 expression in RBC membrane of AAA patients compared to controls were further validated by Western blot, confirming the proteomic results. CONCLUSIONS AND CLINICAL RELEVANCE: RBCs membrane protein composition is altered in AAA patients, which could be involved in the pathological role of RBCs in aortic tissue and become potential targets to prevent AAA progression.
Repisalud
Publicación Artículo científico (JournalArticle)

Adequacy of early-stage breast cancer systemic adjuvant treatment to Saint Gallen-2013 statement: the MCC-Spain study

  • Gómez-Acebo, Inés
  • Dierssen-Sotos, Trinidad
  • Mirones, Mónica
  • Perez-Gomez, Beatriz
  • Guevara, Marcela
  • Amiano, Pilar
  • Sala, María
  • Molina, Antonio J
  • Alonso-Molero, Jéssica
  • Moreno, Victor
  • Suarez-Calleja, Claudia
  • Molina-Barceló, Ana
  • Alguacil, Juan
  • Marcos-Gragera, Rafael
  • Fernández-Ortiz, María
  • Sanz-Guadarrama, Oscar
  • Castaño-Vinyals, Gemma
  • Gil-Majuelo, Leire
  • Moreno-Iribas, Conchi
  • Aragones, Nuria
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
The St Gallen Conference endorsed in 2013 a series of recommendations on early breast cancer treatment. The main purpose of this article is to ascertain the clinical factors associated with St Gallen-2013 recommendations accomplishment. A cohort of 1152 breast cancer cases diagnosed with pathological stage < 3 in Spain between 2008 and 2013 was begun and then followed-up until 2017/2018. Data on patient and tumour characteristics were obtained from medical records, as well as their first line treatment. First line treatments were classified in three categories, according on whether they included the main St Gallen-2013 recommendations, more than those recommended or less than those recommended. Multinomial logistic regression models were carried out to identify factors associated with this classification and Weibull regression models were used to find out the relationship between this classification and survival. About half of the patients were treated according to St Gallen recommendations; 21% were treated over what was recommended and 33% received less treatment than recommended. Factors associated with treatment over the recommendations were stage II (relative risk ratio [RRR] = 4.2, 2.9-5.9), cancer positive to either progesterone (RRR = 8.1, 4.4-14.9) or oestrogen receptors (RRR = 5.7, 3.0-11.0). Instead, factors associated with lower probability of treatment over the recommendations were age (RRR = 0.7 each 10 years, 0.6-0.8), poor differentiation (RRR = 0.09, 0.04-0.19), HER2 positive (RRR = 0.46, 0.26-0.81) and triple negative cancer (RRR = 0.03, 0.01-0.11). Patients treated less than what was recommended in St Gallen had cancers in stage 0 (RRR = 21.6, 7.2-64.5), poorly differentiated (RRR = 1.9, 1.2-2.9), HER2 positive (RRR = 3.4, 2.4-4.9) and luminal B-like subtype (RRR = 3.6, 2.6-5.1). Women over 65 years old had a higher probability of being treated less than what was recommended if they had luminal B-like, HER2 or triple negative cancer. Treatment over St Gallen was associated with younger women and less severe cancers, while treatment under St Gallen was associated with older women, more severe cancers and cancers expressing HER2 receptors.
Repisalud
Publicación Artículo científico (JournalArticle)

Antibody responses to flagellin C and Streptococcus gallolyticus pilus proteins in colorectal cancer

  • Butt, Julia
  • Fernandez de Larrea-Baz, Nerea
  • Tjalsma, Harold
  • Roelofs, Rian
  • Kato, Ikuko
  • Martín, Vicente
  • Perez-Gomez, Beatriz
  • Moreno, Victor
  • Dierssen-Sotos, Trinidad
  • Castilla Catalán, Jesús
  • Fernández-Tardón, Guillermo
  • Amiano, Pilar
  • Salas, Dolores
  • Alguacil, Juan
  • Jimenez-Moleon, Jose J.
  • Huerta, José María
  • de Sanjose, Silvia
  • Del Campo, Rosa
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Pawlita, Michael
  • Waterboer, Tim
  • Boleij, Annemarie
  • Aragones, Nuria
Antibodies to Streptococcus gallolyticus subspecies gallolyticus (SGG) have been associated with colorectal cancer (CRC). Because SGG may correlate with impaired gut epithelia, we assessed the association of antibodies to bacterial flagellin C (FliC), a measure potentially related to this impairment, with CRC and the CRC-specific interaction with antibodies to SGG proteins. Antibodies to FliC and SGG pilus proteins Gallo2178 and Gallo2179 were measured in two independent studies, a combined study from Nijmegen and Detroit (93 CRC cases, 74 controls) and a replication data set including 576 cases and 576 controls from the Spanish multicenter multicase-control study (MCC-Spain). Logistic regression was applied to assess whether antibodies to FliC were associated with CRC and modified the association of antibodies to SGG proteins with CRC. Antibodies to FliC were associated with those to SGG Gallo2178 among CRC cases, resulting in an interaction in the association of antibodies to Gallo2178 with CRC (p = 0.007). This association was only present among individuals with high antibody responses to FliC (OR: 2.42, 95% CI: 1.45-4.06). In conclusion, our findings suggest that colorectal tumorigenesis could be accompanied by an impaired integrity of the epithelium that could result in associated increased antibody responses to bacterial proteins.
Repisalud
Publicación Artículo científico (JournalArticle)

Complement C5 Protein as a Marker of Subclinical Atherosclerosis.

  • Martínez-López, Diego
  • Roldan-Montero, Raquel
  • Garcia-Marques, Fernando
  • Nunez, Estefania
  • Jorge, Inmaculada
  • Camafeita, Emilio
  • Minguez, Pablo
  • Rodriguez de Cordoba, Santiago
  • Lopez-Melgar, Beatriz
  • Lara-Pezzi, Enrique
  • Fernandez-Ortiz, Antonio
  • Ibáñez, Borja
  • Valdivielso, Jose Manuel
  • Fuster, Valentin
  • Michel, Jean-Baptiste
  • Blanco-Colio, Luis Miguel
  • Vazquez, Jesus
  • Martin-Ventura, Jose Luis
The mechanisms underlying early atherosclerotic plaque formation are not completely understood. Moreover, plasma biomarkers of subclinical atherosclerosis are lacking. The purpose of this study was to analyze the temporal and topologically resolved protein changes taking place in human aortas with early atherosclerosis to find new potential diagnostic and/or therapeutic targets. The protein composition of healthy aortas (media layer) or with early atheroma (fatty streak and fibrolipidic, media and intima layers) was analyzed by deep quantitative multiplexed proteomics. Further analysis was performed by Western blot, immunohistochemistry, real-time polymerase chain reaction, and enzyme-linked immunosorbent assay. Plasma levels of complement C5 were analyzed in relation to the presence of generalized (>2 plaques) or incipient (0 to 2 plaques) subclinical atherosclerosis in 2 independent clinical cohorts (PESA [Progression of Early Subclinical Atherosclerosis] [n = 360] and NEFRONA [National Observatory of Atherosclerosis in Nephrology] [n = 394]). Proteins involved in lipid transport, complement system, immunoglobulin superfamily, and hemostasis are increased in early plaques. Components from the complement activation pathway were predominantly increased in the intima of fibrolipidic plaques. Among them, increased C5 protein levels were further confirmed by Western blot, enzyme-linked immunosorbent assay and immunohistochemistry, and associated with in situ complement activation. Plasma C5 was significantly increased in individuals with generalized subclinical atherosclerosis in both PESA and NEFRONA cohorts, independently of risk factors. Moreover, in the PESA study, C5 plasma levels positively correlated with global plaque volume and coronary calcification. Activation of the complement system is a major alteration in early atherosclerotic plaques and is reflected by increased C5 plasma levels, which have promising value as a novel circulating biomarker of subclinical atherosclerosis.
Repisalud
Publicación Artículo científico (JournalArticle)

Proteomic analysis of intraluminal thrombus highlights complement activation in human abdominal aortic aneurysms

  • Martinez-Pinna, Roxana
  • Madrigal-Matute, Julio
  • Tarín, Carlos
  • Burillo, Elena
  • Esteban-Salan, Margarita
  • Pastor-Vargas, Carlos
  • Lindholt, Jes S
  • Lopez, Juan Antonio
  • Calvo, Enrique
  • de Ceniga, Melina Vega
  • Meilhac, Olivier
  • Egido, Jesus
  • Blanco-Colio, Luis M
  • Michel, Jean-Baptiste
  • Martin-Ventura, Jose L
OBJECTIVE: To identify proteins related to intraluminal thrombus biological activities that could help to find novel pathological mechanisms and therapeutic targets for human abdominal aortic aneurysm (AAA). APPROACH AND RESULTS: Tissue-conditioned media from patients with AAA were analyzed by a mass spectrometry-based strategy using liquid chromatography coupled to tandem mass spectrometry. Global pathway analysis by Ingenuity software highlighted the presence of several circulating proteins, among them were proteins from the complement system. Complement C3 concentration and activation were assessed in plasma from AAA patients (small AAA, AAA diameter=3-5 cm and large AAA, AAA diameter >5 cm), showing decreased C3 levels and activation in large AAA patients. No association of a combination of single-nucleotide polymorphisms in complement genes between large and small AAA patients was observed. Intense extracellular C3 inmunostaining, along with C9, was observed in AAA thrombus. Analysis of C3 in AAA tissue homogenates and tissue-conditioned media showed increased levels of C3 in AAA thrombus, as well as proteolytic fragments (C3a/C3c/C3dg), suggesting its local deposition and activation. Finally, the functional role of local complement activation in polymorphonuclear (PMN) cell activation was tested, showing that C3 blockade by anti-C3 antibody was able to decrease thrombus-induced neutrophil chemotaxis and reactive oxygen species production. CONCLUSIONS: A decrease of systemic C3 concentration and activity in the later stages of AAA associated with local complement retention, consumption, and proteolysis in the thrombus could induce PMN chemotaxis and activation, playing a detrimental role in AAA progression.
Repisalud
Publicación Artículo científico (JournalArticle)

Quality of Life in a Cohort of 1078 Women Diagnosed with Breast Cancer in Spain: 7-Year Follow-Up Results in the MCC-Spain Study

  • Alonso-Molero, Jéssica
  • Dierssen-Sotos, Trinidad
  • Gómez-Acebo, Inés
  • Fernandez de Larrea-Baz, Nerea
  • Guevara, Marcela
  • Amiano, Pilar
  • Castaño-Vinyals, Gemma
  • Fernández-Villa, Tania
  • Moreno, Victor
  • Bayo, Juan
  • Molina-Barceló, Ana
  • Fernández-Ortíz, María
  • Suarez-Calleja, Claudia
  • Marcos-Gragera, Rafael
  • Castells, Xavier
  • Gil-Majuelo, Leire
  • Ardanaz, Eva
  • Perez-Gomez, Beatriz
  • Kogevinas, Manolis
  • Pollan-Santamaria, Marina
  • Llorca, Javier
Breast cancer is the most frequent cause of tumors and net survival is increasing. Achieving a higher survival probability reinforces the importance of studying health-related quality of life (HR-QoL). The main aim of this work is to test the relationship between different sociodemographic, clinical and tumor-intrinsic characteristics, and treatment received with HR-QoL measured using SF-12 and the FACT/NCCN (National Comprehensive Cancer Network/Functional Assessment of Cancer Therapy) Breast Symptom Index (FBSI). Women with breast cancer recruited between 2008 and 2013 and followed-up until 2017-2018 in a prospective cohort answered two HR-QoL surveys: the SF-12 and FBSI. The scores obtained were related to woman and tumor characteristics using linear regression models. The telephone survey was answered by 1078 women out of 1685 with medical record follow-up (64%). Increases in all three HR-QoL scores were associated with higher educational level. The score differences between women with university qualifications and women with no schooling were 5.43 for PCS-12, 6.13 for MCS-12 and 4.29 for FBSI. Histological grade at diagnosis and recurrence in the follow-up displayed a significant association with mental and physical HR-QoL, respectively. First-line treatment received was not associated with HR-QoL scores. On the other hand, most tumor characteristics were not associated with HR-QoL. As breast cancer survival is improving, further studies are needed to ascertain if these differences still hold in the long run.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Contaminación superficial del Mediterraneo Noroccidental: detección de derrames de crudo

  • Platónov, Alexéi Konstantínovich
  • Redondo Apraiz, José Manuel
[ES] Se presenta una continuación temática del artículo “Aplicación de las imágenes SAR en el estudio de la dinámica de las aguas y de la polución del Mar Mediterráneo cerca de Barcelona”, publicado en la Revista “Ingeniería del Agua”, Vol. 8, N1 en marzo de 2001. Ahora el área de estudio se amplió y comprende toda la zona del Mediterráneo Noroccidental MN, es decir incluye el Mar Balear y el Golfo de León. Los resultados del análisis de cerca de 330 imágenes del Radar de Apertura Sintética, obtenidas mediante los proyectos Clean Seas, ERS-1/2 SAR Exploitation Study in Catalonia y Oil Watchnos permitieron obtener una visión general, pero estadísticamente justificada, sobre el estado del ambiente marino del MN en los años 1996 – 1998. Se constata que las rutas marítimas cercanas a Marseille están más limpias que cerca de Barcelona. Se evalúa la contaminación total del área, la contribución de los penachos de aguas residuales procedentes de los ríos regionales y de los pequeños pero “habitual, Agradecemos al Ministerio de Educación, Cultura y Deporte de España (SB2000-0076) y al Ministerio de Ciencia y Tecnología (FTN-2001-2220) por su ayuda financiera.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Control predictivo en microrredes interconectadas y con vehículos eléctricos, Model predictive control of interconnected microgrids and electric vehicles

  • Bordons, C.
  • Garcia-Torres, F.
  • Ridao, M.A.
[ES] La microrred como elemento agregador de fuentes de generación, cargas y sistemas de almacenamiento de energía aparece como tecnología clave para dotar a los sistemas eléctricos de suficiente flexibilidad para una transición energética basada en fuentes renovables. Sin embargo, el problema de control para la gestión de energía se vuelve complejo cuando se incrementa el número de sistemas conectados a una misma microrred. De igual forma, se requiere flexibilidad para integrar a los vehículos eléctricos. La interacción entre las distintas microrredes y los vehículos hacen necesarias herramientas avanzadas de control para resolver el problema de optimización. El objeto del presente trabajo es presentar distintas herramientas de control predictivo basado en el modelo (Model Predictive Control, MPC) para resolver el problema de control asociado a este tipo de sistemas. En concreto, se abordan dos problemas: la conexión de vehículos eléctricos a la microrred y la interconexión de varias microrredes. Para el primer caso se analizan dos escenarios, según que el intercambio de energía sea uni o bidireccional y se presenta la forma de optimizar la operación usando MPC. En el segundo caso se aborda el problema usando técnicas de control distribuido., [EN] Microgrids, as aggregators of sources, loads and energy storage systems, appear as key technology to provide the required flexibility to electric power systems to carry out an energy transition based on renewable sources. Nevertheless, the control problem becomes complex when the number of connected components to the same microgrid increases. Also, the system requires flexibility to integrate electric vehicles. The complexity given by the associated control problem to optimize the energy exchange between microgrids and the electric vehicles makes necessary the development of advanced control tools. In this work, dierent Model Predictive Control (MPC) strategies are introduced in order to face the challenge of the control problem formulation of this kind of systems. Specifically, two problems are addressed: the connection of electric vehicles to the microgrid and the interconnection of several microgrids. For the first case, two scenarios are analyzed, depending on whether the energy exchange is uni or bidirectional, the way to optimize the operation using MPC is presented and examples of use are shown. For the second case, the problem isaddressed using distributed control techniques., Este trabajo ha sido realizado parcialmente gracias al apoyo del Ministerio de Economía, Industria y Competitividad de España mediante el proyecto CONFIGURA (DPI2016-78338-R) y por la Comisión Europea, en el proyecto AGERAR (0076-AGERAR-6-E), dentro del programa Interreg Spain-Portugal (POCTEP).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Big Pharma, Little Science? A bibliometric perspective on big pharma&apos, s R&amp, D decline

  • Ismael Rafols
  • Hopkins, M.M.
  • Hoekman, J.
  • Siepel, J.
  • O&apos;Hare, A.
  • Perianes-Rodriguez, A.
  • Nightingale, P.
There is a widespread perception that pharmaceutical R&D is facing a productivity crisis characterised by stagnation in the numbers of new drug approvals in the face of increasing R&D costs. This study explores pharmaceutical R&D dynamics by examining the publication activities of all R&D laboratories of the major European and US pharmaceutical firms (Big Pharma) during the period 1995-2009. The empirical findings present an industry in transformation. In the first place, we observe a decline of the total number of publications by large firms. Second, we show a relative increase of their external collaborations suggesting a tendency to outsource, and a diversification of the disciplinary base, in particular towards computation, health services and more clinical approaches. Also evident is a more pronounced decline in publications by both R&D laboratories located in Europe and by firms with European headquarters. Finally, while publications by Big Pharma in emerging economies sharply increase, they remain extremely low compared with those in developed countries. In summary, the trend in this transformation is one of a gradual decrease in internal research efforts and increasing reliance on external research. These empirical insights support the view that Big Pharma are increasingly becoming 'network integrators' rather than the prime locus of drug discovery., We thank Mike O'Neill, Luigi Orsenigo and Sergio Sismondo for comments. Ismael Rafols and Alice O'Hare were funded by the EU FP7 project FRIDA(Grant 225546, http://www.fridaproject.eu) and the US NSF (Award no. 0830207, http://idr.gatech.edu/). Michael Hopkins and Josh Siepel were supported by ESRC grant RES-360-25-0076. Jarno Hoekman has been supported by the Netherlands Organisation for Scientific Research (NWO) under the VIDI programme, number 452-06-005. Antonio Perianes-Rodríguez conducted his research at the University of Sussex as awardee of José Castillejo grant, JC2010-0042, funded by the Spanish Ministry of Education. The findings and observations contained in this paper are those of the authors and do not necessarily reflect the views of the funders.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Interactive Overlay Maps for US Patent (USPTO) Data Based on International Patent Classifications (IPC)

  • Leydesdorff, L.
  • Kushnir, Duncan
  • Ismael Rafols
[EN] We report on the development of an interface to the US Patent and Trademark Office (USPTO) that allows for the mapping of patent portfolios as overlays to basemaps constructed from citation relations among all patents contained in this database during the period 1976-2011. Both the interface and the data are in the public domain; the freeware programs VOSViewer and/or Pajek can be used for the visualization. These basemaps and overlays can be generated at both the 3-digit and 4-digit levels of the International Patent Classification (IPC) of the world intellectual property organization (WIPO). The basemaps can provide a stable mental framework for analysts to follow developments over searches for different years, which can be animated. The full flexibility of the advanced search engines of USPTO are available for generating sets of patents and/or patent applications which can thus be visualized and compared. This instrument allows for addressing questions about technological distance, diversity in portfolios, and animating the developments of both technologies and technological capacities of organizations over time., We acknowledge support by the ESRC project 'Mapping the Dynamics of Emergent Technologies' (RES-360-25-0076). We are grateful to Nils Newman and Antoine Schoen for previous comments and communications.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Global Maps of Science based on the new Web-of-Science Categories

  • Leydesdorff, L.
  • Carley, S.
  • Ismael Rafols
[EN] In August 2011, Thomson Reuters launched version 5 of the Science and Social Science Citation Index in the Web of Science (WoS). Among other things, the 222 ISI Subject Categories (SCs) for these two databases in version 4 of WoS were renamed and extended to 225 WoS Categories (WCs). A new set of 151 Subject Areas was added, but at a higher level of aggregation. Perhaps confusingly, these Subject Areas are now abbreviated "SC'' in the download, whereas "WC'' is used for WoS Categories. Since we previously used the ISI SCs as the baseline for a global map in Pajek (Pajek is freely available at http://vlado.fmf.uni-lj.si/pub/networks/pajek/) (Rafols et al., Journal of the American Society for Information Science and Technology 61:1871-1887, 2010) and brought this facility online (at http://www.leydesdorff.net/overlaytoolkit), we recalibrated this map for the new WC categories using the Journal Citation Reports 2010. In the new installation, the base maps can also be made using VOSviewer (VOSviewer is freely available at http://www.VOSviewer.com/) (Van Eck and Waltman, Scientometrics 84:523-538, 2010)., We acknowledge support from the ESRC grant RES-360-25-0076
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Bibliometric perspectives on medical innovation using the medical subject Headings of Pubmed

  • Leydesdorff, L.
  • Rotolo, D.
  • Rafols García, Ismael
Multiple perspectives on the nonlinear processes of medical innovations can be distinguished and combined using the Medical Subject Headings (MeSH) of the MEDLINE database. Focusing on three main branches-"diseases," "drugs and chemicals," and "techniques and equipment"-we use base maps and overlay techniques to investigate the translations and interactions and thus to gain a bibliometric perspective on the dynamics of medical innovations. To this end, we first analyze the MEDLINE database, the MeSH index tree, and the various options for a static mapping from different perspectives and at different levels of aggregation. Following a specific innovation (RNA interference) over time, the notion of a trajectory which leaves a signature in the database is elaborated. Can the detailed index terms describing the dynamics of research be used to predict the diffusion dynamics of research results? Possibilities are specified for further integration between the MEDLINE database on one hand, and the Science Citation Index and Scopus (containing citation information) on the other. © 2012 ASIS&T., We acknowledge support by the ESRC project "Mapping the Dynamics of Emergent Technologies" (RES-360-25-0076). Ismael Rafols acknowledges funding from U.S. National Science Foundation (Award 0830207, "Measuring and Tracking Research Knowledge Integration"). The findings and observations contained in this article are those of the authors and do not necessarily reflect the views of the funding agencies. We are grateful to Lutz Bornmann and Tobias Opthof for comments on previous drafts.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Muscle-Targeted Robotic Assistance and Augmentation of Human Motion

  • Escarabajal, Rafael J.
  • Paris, Elena
  • Jamsek, Marko
  • Petric, Tadej
  • Babic, Jan
  • Valera Fernández, Ángel|||0000-0001-6843-6394
  • Mata Amela, Vicente|||0000-0003-2255-0567
[EN] This article presents a novel control framework for assisting human arm movements with a robotic device. Unlike existing collaborative and wearable robots that predominantly operate in task space or joint space, our framework focuses on controlling variables related to the muscular space, which refers to the activation and force generation of individual muscles. Translating these variables to the robot's actuation space is challenging, which hinders the development of human-centered tasks and limits the transparency of robotic assistance for the central nervous system. To address these issues, we consider the relationship between the muscular space and the robot's task space, using the kinematics and dynamics of the human limb obtained from a calibrated musculoskeletal model based on Hill's muscle model. Our framework includes two muscle-targeted methods: assistance and augmentation. The assistance method allows exercise or rehabilitation of specific muscles, while the augmentation method achieves isotropic manipulability, enabling the user to exert forces uniformly in all directions using the novel concept of a force envelope. The experiments were conducted using a haptic robot in admittance mode with a viscous environment simulating a load. The results demonstrate significant improvement in the prediction capabilities of the calibrated model compared with the baseline. Muscle-targeted assistance induces substantial changes in targeted muscular efforts. In addition, we achieve isotropic manipulability in a more precise way as compared with previous methods. In summary, our proposed control framework proves effective in assisting human arm movements with a robotic device for rehabilitation and power augmentation in human-centered applications., This work was supported in part by the Generalitat Valenciana, Conselleria d'Innovacio, Universitats, Ciencia i Societat under Grant CIAICO/2023/074; in part by the Vicerrectorado de Investigacion de la Universitat Politecnica de Valencia under Grant PAID-11-21, in part by Slovenian Research Agency under Program P2-0076; and in part by the European Union's Horizon Europe research and innovation programme under Grant Agreement 101120408-SWAG.
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Interactive overlays of journals and the measurement of interdisciplinarity on the basis of aggregated journal-journal citations

  • Leydesdorff, L.
  • Rafols García, Ismael
  • Chen, C.
sing the option Analyze Results with the Web of Science, one can directly generate overlays onto global journal maps of science. The maps are based on the 10,000+ journals contained in the Journal Citation Reports (JCR) of the Science and Social Sciences Citation Indices (2011). The disciplinary diversity of the retrieval is measured in terms of Rao-Stirling's quadratic entropy (Izsak & Papp, 1995). Since this indicator of interdisciplinarity is normalized between 0 and 1, interdisciplinarity can be compared among document sets and across years, cited or citing. The colors used for the overlays are based on Blondel, Guillaume, Lambiotte, and Lefebvre's (2008) community-finding algorithms operating on the relations among journals included in the JCR. The results can be exported from VOSViewer with different options such as proportional labels, heat maps, or cluster density maps. The maps can also be web-started or animated (e.g., using PowerPoint). The citing dimension of the aggregated journal-journal citation matrix was found to provide a more comprehensive description than the matrix based on the cited archive. The relations between local and global maps and their different functions in studying the sciences in terms of journal literatures are further discussed: Local and global maps are based on different assumptions and can be expected to serve different purposes for the explanation., We thank Nees Jan van Eck and Ludo Waltman for suggestions and comments, and Thomson Reuters for access to the data. Supported by the ESRC project, Mapping the Dynamics of Emergent Technologies (RES-360-25-0076).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Research portfolios in science policy: moving from financial returns to societal benefits

  • Wallace, Matthew
  • Ismael Rafols
[EN] Funding agencies and large public scientific institutions are increasingly using the term "research portfolio" as a means of characterizing their research. While portfolios have long been used as a heuristic for managing corporate R&D (i.e. R&D aimed at gaining tangible economic benefits), they remain ill-defined in a science policy context where research is aimed at achieving societal outcomes. In this article we analyze the discursive uses of the term "research portfolio" and propose some general considerations for their application in science policy. We explore the use of the term in private R&D and related scholarly literature in existing science policy practices, and seek insight in relevant literature in science policy scholarship. While the financial analogy can in some instances be instructive, a simple transposition from the world of finance or of corporate R&D to public research is problematic. However, we do identify potentially fruitful uses of portfolio analysis in science policy. In particular, our review suggests that the concept of research portfolio can indeed be a useful analytical instrument for tackling complex societal challenges. Specifically, the strands of scholarship identified suggest that the use of research portfolio should: i) recognize the diversity of research lines relevant for a given societal challenge, given the uncertainty and ambiguity of research outcomes; ii) examine the relationships between research options of a portfolio and the expected societal outcomes; and iii) adopt a systemic perspective to research portfolios - i.e. examine a portfolio as a functional whole, rather than as the sum of its parts. We argue that with these considerations, portfolio-driven approaches may foster social inclusion in science policy decisions, help deliberation between "alternative" portfolios to tackle complex societal challenges, as well as promote cost-effectiveness and transparency., We thank Tommaso Ciarli, Jochen Glaser, Jordi Molas-Gallart, Richard Wooley, and two anonymous referees for their insightful comments and suggestions. We acknowledge support from the UK Economic and Social Research Council (Grant RES-360-25-0076, Mapping the Development of Emergent Technologies) and the FP7 EU Marie Curie Integration Grant to IR (MapRePort).
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Expression profile of microRNAs related with viral infectivity, inflammatory response, and immune activation in people living with HIV

  • Cuesta Sancho, Sara
  • Márquez Ruiz, Denisse
  • Illanes Álvarez, Francisco
  • Campaña Gómez, Irene
  • Martín Aspas, Andrés
  • Trujillo Soto, María Teresa
  • Romero, Alberto
  • Galán Sánchez, Fátima
  • Rodríguez Iglesias, Manuel Antonio
  • Márquez Coello, María de las Mercedes
  • Girón González, José Antonio
Objective: To evaluate the serum expression of microRNAs (miRNAs) with ability to modulate the human immunodeficiency (HIV) replication or inflammatory status in people living with HIV (PLWH). Methods: Forty healthy controls and two groups of PLWH were evaluated: (a) Group 1 (n = 30), patients with detectable viral load at inclusion, analyzed before receiving antiretroviral therapy (ART) and 12 months after initiating it; (b) Group 2 (n = 55), PLWH with prolonged undetectable viral load. Intestinal barrier disruption (I-FABP) and bacterial translocation (16S rDNA) markers, inflammatory markers such as interleukin (IL)-6 and sCD163, immune activation and expression of specific miRNAs were evaluated. Results: Serum concentrations of I-FABP, 16S rDNA, IL-6, sCD163 and activated T lymphocytes were increased in PLWH. Serum miR-34a was overexpressed at inclusion and remained elevated after ART. The expression of the remaining miRNAs that modulate HIV infectivity (miR-7, mir-29a, miR-150, and miR-223) was similar in PLWH and controls. Related to miRNAs implicated in inflammation (miR-21, miR-155, and miR-210), significant overexpression were observed in miR-21 and miR-210 levels in untreated PLWH, but levels were restored in those patients treated for a long period. Conclusion: A sustained overexpression of miR-34a was detected even after prolonged HIV controlled replication. miR-21 and miR-210 can be considered new markers of inflammation with high sensitivity to its modifications., 12 páginas
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Artículo científico (JournalArticle)

Hepatitis C: Problems to extinction and residual hepatic and extrahepatic lesions after sustained virological response

  • Cuesta Sancho, Sara
  • Márquez Coello, María de las Mercedes
  • Illanes Álvarez, Francisco
  • Márquez Ruiz, Denisse
  • Arizcorreta Yarza, Ana
  • Galán Sánchez, Fátima
  • Montiel, Natalia
  • Rodríguez Iglesias, Manuel Antonio
  • Girón González, José Antonio
Loss of follow-up or reinfections hinder the expectations of hepatitis C eradication despite the existence of highly effective treatments. Moreover, the elimination of the infection does not imply the reversion of those chronic alterations derived from the previous infection by hepatitis C virus (HCV). This review analyzes the risk factors associated with loss to follow-up in diagnosis or treatment, and the possibility of reinfection. Likewise, it assesses the residual alterations induced by chronic HCV infection considering the liver alterations (inflammation, fibrosis, risk of decompensation, hepatocellular carcinoma, liver transplantation) and, on the other hand, the comorbidities and extrahepatic manifestations (cryoglobulinemia, non-Hodgkin lymphoma, peripheral insulin resistance, and lipid, bone and cognitive alterations). Peculiarities present in subjects coinfected with human immunodeficiency virus are analyzed in each section.
RODIN. Repositorio de Objetos de Docencia e Investigación de la Universidad de Cádiz
Publicación Tesis doctoral (DoctoralThesis)

Relación entre NETs, microbiota intestinal y translocación bacteriana en pacientes infectados por VIH y en un modelo animal con depleción de BATF

  • Illanes Álvarez, Francisco
CONOCIMIENTOS PREVIOS Las personas que viven con VIH (PLWH), incluso tras conseguir una carga viral indetectable gracias a tratamientos antirretrovirales (TAR), presentan una activación inmune e inflamatoria persistente, en la que participan distintas células inmunes. Entre éstas, la implicación de los polimorfonucleares neutrófilos, particularmente a través de la formación y liberación de trampas extracelulares de neutrófilos (NETs, NETosis), ha sido escasamente estudiada. Como consecuencia de la activación inmune e inflamatoria persistente, las PLWH tienen mayor riesgo de desarrollar enfermedades cardiovasculares. Entre los factores clave que contribuyen a este estado de activación inmune e inflamatoria se encuentran la alteración de la microbiota y la barrera intestinal. El modelo de ratones Batf-/- (knock-out), que presenta un déficit de linfocitos Th17 similar al observado en PLWH con carga viral controlada, permite estudiar estos fenómenos en condiciones controladas. OBJETIVOS En PLWH con carga viral indetectable, se plantea como objetivo evaluar la composición de la microbiota fecal y su relación con diversos parámetros de salud intestinal, activación inmunológica y patología vascular. Se plantean como objetivos concretos analizar la composición de la microbiota intestinal, el estado de la barrera intestinal, la translocación bacteriana; evaluar el estado de activación inflamatoria (incluyendo la formación de NETs) e inmune y correlacionarla con los anteriores; y finalmente, analizar el estado de activación vascular y plaquetaria y la presencia de aterosclerosis subclínica carotídea, como una función de los anteriores y de los factores clásicos de aterosclerosis. Se considerará la influencia de las prácticas sexuales, la adherencia a la dieta mediterránea y la TAR de las PLWH. En el modelo animal, se plantea como objetivo el estudio de los efectos de la deficiencia de Batf en las alteraciones de la pared intestinal, y su relación con la composición de la microbiota fecal y la translocación bacteriana. También se evaluará la situación inmune e inflamatoria, y los efectos de la suplementación de la dieta con prebióticos o probióticos en estos parámetros. METODOLOGÍA Se seleccionó una muestra de 120 PLWH con infección crónica y carga de VIH indetectable, y 30 controles sanos emparejados por edad y sexo. Se analizaron la diversidad y composición de la microbiota intestinal, así como los marcadores de integridad intestinal (intestinal fatty acid binding protein, I-FABP), translocación bacteriana (ADNr bacteriano 16S), activación inmune (linfocitos T activados), inflamatoria (interleucina 6 IL-6, CD163 soluble sCD163, proteína C reactiva de alta sensibilidad hsCRP, formación de NETs), endotelial (E-selectina, molécula de adhesión de células vasculares 1 VCAM-1) y plaquetaria (P-selectina, factor plaquetario 4 PF4), y factores de riesgo cardiovascular incluidos en las escalas REGICOR y ASCVD. Se estudió la existencia de aterosclerosis subclínica, detectada mediante ecografía Doppler carotídea, así como el efecto sobre los parámetros mencionados de la TAR, la adherencia a la dieta mediterránea (evaluada mediante un cuestionario de 14 preguntas) o el tipo de prácticas sexuales. Se realizaron estudios similares en ratones Batf-/- y WT, evaluándose en ellos también la microbiota intestinal, la integridad intestinal (mediante la expresión de los genes Tjp1 y Ocln y la concentración sérica de I-FABP), translocación bacteriana (aislamiento microbiológico en ganglios mesentéricos), activación inmune (CD4 CD38 y CD8 CD38 ) e inflamatoria (CD14 soluble e IL-6). Además, se analizó el efecto de la suplementación de la dieta con prebiótico (maltodextrina resistente a la digestión) o probiótico (preparado comercial multicepa). RESULTADOS Los hallazgos indican que las PLWH muestran una alteración significativa de la microbiota intestinal, caracterizada por una menor abundancia de géneros estimulantes de la síntesis de moco de adecuada calidad e implicados en la eliminación de sustancias nocivas para la pared; y no tanto en la producción de ácidos grasos de cadena corta, o por un exceso de géneros con mayor capacidad de translocación. Las modificaciones en la microbiota intestinal están influenciadas levemente por el tratamiento antirretroviral o la dieta, y de un modo más significativo por las prácticas sexuales. Las PLWH presentan una activación inflamatoria caracterizada, entre otras, por la mayor formación de NETs, así como una activación plaquetaria y del sistema de la coagulación/fibrinolisis. La prevalencia de alteraciones aterosclerosas es significativamente mayor que la de la población control. Las PLWH con lesión carotídea definida presentaron unos índices de riesgo cardiovascular (medidos por las escalas REGICOR y ASCVD) significativamente superiores a los de los controles sanos, así como una menor adherencia a la dieta mediterránea y una mayor activación inflamatoria (manifestada por el incremento de IL-6 y NETs). Los factores implicados de modo independiente en la lesión carotídea fueron el índice REGICOR y la concentración sérica de IL-6. En el modelo animal, se observó una mayor frecuencia de microorganismos en los ganglios linfáticos mesentéricos de los ratones Batf-/- que en los de los ratones WT (wild type), lo que implica una mayor translocación bacteriana. Estos ratones Batf-/- mostraron una mayor activación inflamatoria e inmune. La suplementación con probióticos determinó un enriquecimiento en la microbiota fecal de Candidatus Arthromitus, una bacteria filamentosa segmentada, y concomitantemente un aumento del recuento de linfocitos Th17 y un descenso de marcadores de activación inflamatoria e inmune periférica. CONCLUSIONES Las PLWH, a pesar de mantener el control de la replicación viral de modo prolongado, presentan alteraciones de la microbiota intestinal, caracterizadas por una disminución de géneros con características beneficiosas. Las conductas sexuales influencian marcadamente la microbiota intestinal. Las PLWH presentan una mayor translocación bacteriana, activación inmune e inflamatoria (incluyendo en la misma la mayor producción de NETs), activación plaquetaria y del sistema de coagulación/fibrinolisis, así como una mayor prevalencia de aterosclerosis carotídea. Esta última está independientemente influenciada por los factores clásicos de riesgo cardiovascular y por la activación inflamatoria. Los ratones Batf-/- son un buen modelo de estudio de translocación bacteriana, activación inflamatoria e inmune, con notables similitudes a las presentes en PLWH con carga viral indetectable. En este modelo animal, el uso de probióticos se asocia a una reducción de la activación inmune e inflamatoria y a un incremento del recuento de linfocitos Th17., Background People living with HIV (PLWH), even after achieving an undetectable viral load thanks to antiretroviral treatments (ART), present a persistent immune and inflammatory activation, in which different immune cells participate. Among these, the involvement of polymorphonuclear neutrophils, particularly through the formation and release of neutrophil extracellular traps (NETs, NETosis), has been scarcely studied. As a consequence of persistent immune and inflammatory activation, PLWH have a higher risk of developing cardiovascular diseases. Among the key factors that contribute to this state of immune and inflammatory activation are the alteration of the microbiota and the intestinal barrier. The Batf−/− mouse model, which presents a deficit of Th17 lymphocytes similar to that observed in PLWH with controlled viral load, allows to study these phenomena under controlled conditions. Objectives In PLWH with undetectable viral load, the objective is to evaluate the composition of the fecal microbiota and its relationship with various parameters of intestinal health, immune activation and vascular pathology. The specific objectives are to analyze the composition of the intestinal microbiota, the state of the intestinal barrier, bacterial translocation; to evaluate the state of inflammatory activation (including the formation of NETs) and immune activation and correlate it with the above; and finally, to analyze the state of vascular and platelet activation and the presence of subclinical carotid atherosclerosis, as a function of the above and of the classic factors of atherosclerosis. The influence of sexual practices, adherence to the Mediterranean diet and ART in PLWH will be considered. In the animal model, the objective is to study the effects of Batf deficiency on intestinal wall alterations, and its relationship with the composition of the fecal microbiota and bacterial translocation. The immune and inflammatory status will also be evaluated, as well as the effects of dietary supplementation with prebiotics or probiotics on these parameters. Methodology A sample of 120 chronically infected PLWH with undetectable HIV load and 30 age- and sexmatched healthy controls was selected. The diversity and composition of the intestinal microbiota, as well as markers of intestinal integrity (intestinal fatty acid binding protein, IFABP), bacterial translocation (bacterial 16S rDNA), immune (activated T cells), inflammatory (interleukin 6 −IL-6−, soluble CD163 −sCD163−, high-sensitivity C-reactive protein −hsCRP−, NET formation), endothelial (E-selectin, vascular cell adhesion molecule 1 −VCAM-1−) and platelet (P-selectin, platelet factor 4 −PF4−) activation, and cardiovascular risk factors included in the REGICOR and ASCVD scales were analyzed. The existence of subclinical atherosclerosis, detected by carotid Doppler ultrasound, was studied, as well as the effect on the aforementioned parameters of ART, adherence to the Mediterranean diet (assessed by a 14-item questionnaire) or the type of sexual practices. Similar studies were carried out in Batf−/− and WT mice, evaluating intestinal microbiota, intestinal integrity (through the expression of Tjp1 and Ocln genes and serum concentration of I-FABP), bacterial translocation (microbiological isolation in mesenteric ganglia), immune activation (CD4+CD38+ and CD8+CD38+ ) and inflammatory activation (soluble CD14 and IL-6). In addition, the effect of supplementing the diet with prebiotic (digestion-resistant maltodextrin) or probiotic (multi-strain commercial preparation) was analyzed. Results Research findings reveal that PLWH show significant alterations in their intestinal microbiota. These changes are characterized by a lower abundance of genera that stimulate the synthesis of mucus of adequate quality or are involved in eliminating substances harmful to the intestinal wall; and less pronounced in the production of short-chain fatty acids or in an excess of genera with a greater translocation capacity. The modifications in the intestinal microbiota are slightly influenced by antiretroviral treatment or diet, and more significantly by sexual practices. PLWH present inflammatory activation characterized, notably marked by increased formation of NETs, as well as heightened activation of platelets and the coagulation/fibrinolysis system. The prevalence of atherosclerotic alterations in this group is significantly higher compared to the control population. PLWH with defined carotid injury exhibited markedly higher cardiovascular risk indices, as measured by the REGICOR and ASCVD scores, compared to healthy controls, as well as lower adherence to the Mediterranean diet and higher inflammatory activation, evidenced by increased IL-6 and NETs. The REGICOR index and serum IL-6 concentration were identified as independent factors implicated in carotid injury In the animal modelstudies, Batf−/− mice displayed a higher frequency of microorganisms in their mesenteric lymph nodes compared to wild type (WT) mice, indicating increased bacterial translocation. These Batf−/− mice also showed greater inflammatory and immune activation. Probiotic supplementation determined an enrichment in the fecal microbiota of Candidatus Arthromitus, a segmented filamentous bacterium. This enrichment was accompanied by an increase in Th17 lymphocyte count and a decrease in markers of peripheral inflammatory and immune activation. Conclusions Despite maintaining prolonged control of viral replication, PLWH present alterations in the intestinal microbiota, characterized by a decrease in genera with beneficial characteristics. Sexual behaviors markedly influence the intestinal microbiota. PLWH present greater bacterial translocation, immune and inflammatory activation (including increased production of NETs), platelet activation and coagulation/fibrinolysis system, as well as a higher prevalence of carotid atherosclerosis. The latter is independently influenced by classic cardiovascular risk factors and inflammatory activation. Batf−/− mice are a good model for studying bacterial translocation, inflammatory and immune activation, with notable similarities to those present in PLWH with undetectable viral load. In this animal model, the use of probiotics is associated with a reduction in immune and inflammatory activation and an increase in the Th17 lymphocyte count.
Arias Montano. Repositorio Institucional de la Universidad de Huelva
Publicación Artículo científico (JournalArticle)

Colorectal cancer, sun exposure and dietary vitamin D and calcium intake in the MCC-Spain study

  • Vallès, Xavier
  • Henar Alonso, M.
  • López Caleya, Juan Francisco
  • Capelo Álvarez, Rocío
Objectives: To explore the association of colorectal cancer with environmental solar radiation and sun exposure behavior, considering phenotypic variables (eye color, hair color and skin phenotype), dietary intake of vitamin D and calcium, and socio-demographic factors. Study design: Multicenter population-based frequency matched case-control study in Spain (MCC-Spain), with 2140 CRC cases and 3950 controls. Methods: Data were obtained through personal interviews using a structured epidemiological questionnaire that included socio-demographic data, residential history, environmental exposures, behavior, phenotypic and dietary information. An environmental-lifetime sun exposure score was constructed combining residential history and average daily solar radiation, direct and diffuse. Logistic regression was used to explore the association between different variables. A structural equation model was used to verify the associations of the conceptual model. Results: We found a lower risk of CRC in subjects frequently exposed to sunlight during the previous summer and skin burning due to sun exposure. No association was observed in relation to the residential solar radiation scores. Subjects with light eye or light hair colors had a lower risk of CRC that those with darker colors. Dietary calcium and vitamin D were also protective factors, but not in the multivariate model. The structural equation model analysis suggested that higher sun exposure was associated with a decreased risk of CRC, as well as dietary intake of calcium and vitamin D, and these factors are correlated among themselves and with environmental solar radiation and skin phenotypes. Conclusion: The results agree with previous observations that sun exposure, dietary vitamin D and calcium intake, and serum 25(OH)D concentration reduce the risk of CRC and indicate that these factors may be relevant for cancer prevention.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

  • Roldán-Montero, R
  • Pérez-Sáez, Juan M.
  • Cerro-Pardo, Isabel
  • Oller, Jorge
  • Martinez-Lopez, Diego
  • Nuñez, Estefania
  • Maller, Sebastian M.
  • Gutierrez-Muñoz, Carmen
  • Mendez-Barbero, Nerea
  • Escola-Gil, Joan C.
  • Michel, Jean-Baptiste
  • Mittelbrunn, Maria
  • Vázquez, Jesús
  • Blanco-Colio, Luis M.
  • Rabinovich, Gabriel A.
  • Martín-Ventura, Jose Luis
Pathological vascular remodeling is the underlying cause of atherosclerosis and abdominal aortic aneurysm (AAA). Here, we analyzed the role of galectin-1 (Gal-1), a β-galactoside-binding protein, as a therapeutic target for atherosclerosis and AAA. Mice lacking Gal-1 (Lgals1-/-) developed severe atherosclerosis induced by pAAV/D377Y-mPCSK9 adenovirus and displayed higher lipid levels and lower expression of contractile markers of vascular smooth muscle cells (VSMCs) in plaques than wild-type mice. Proteomic analysis of Lgals1-/- aortas showed changes in markers of VSMC phenotypic switch and altered composition of mitochondrial proteins. Mechanistically, Gal-1 silencing resulted in increased foam cell formation and mitochondrial dysfunction in VSMCs, while treatment with recombinant Gal-1 (rGal-1) prevented these effects. Furthermore, rGal-1 treatment attenuated atherosclerosis and elastase-induced AAA, leading to higher contractile VSMCs in aortic tissues. Gal-1 expression decreased in human atheroma and AAA compared to control tissue. Thus, Gal-1-driven circuits emerge as potential therapeutic strategies in atherosclerosis and AAA., This study was funded by the Spanish MINECO (PID2019-106814RB-I00 and PGC2018-097019-B-I00), CAM (Complemento II-CM, S2017/BMD-3673), Fondo de Investigaciones Sanitarias ISCiii-FEDER [Biobancos RD09/0076/00101 and PRB3 (IPT17/0019, ProteoRed)], and FEDER “Una manera de hacer Europa.” CIBERCV and CIBERDEM are Instituto de Salud Carlos III projects. This work also received funding from “La Caixa” Banking Foundation under the project code HR17-00247. The CNIC is supported by Instituto de Salud Carlos III (ISCIII), Ministerio de Ciencia, Innovación y Universidades (MCNU), and Pro CNIC Foundation and is a Severo Ochoa Center of Excellence (SEV-2015-0505). Further support was provided by Santander-UAM, Agencia Nacional de Promoción de la Investigación, el Desarrollo Tecnológico y la Innovación (PICT 2010-870, Argentina), Fundación Sales, and Fundación Bunge y Born (Argentina). We thank the support of Ferioli, Ostry, and Caraballo families
UPCommons. Portal del coneixement obert de la UPC
Publicación Contribución de congreso (ConferenceOutput)

Sample quality examination on silty soils, Qualité des echantillons dans sols limoneux

  • Arroyo Álvarez de Toledo, Marcos|||0000-0001-9384-9107
  • Pineda Jiménez, Jubert Andrés
  • Sau Valenzuela, Núria
  • Devincenzi, M.J.
  • Pérez, N.
Mediterranean deltaic environments typically produce soil deposits in which silts dominate, granular intercalations are frequent and the mineralogy includes an important carbonate fraction. One question still open is what sampling methods are most appropriate to recover undisturbed samples from these deposits and how best to evaluate disturbance on samples recovered from them. In this paper we present results from a testing campaign on silty deposits in which several sampling methods (Sherbrooke, Osterberg, Shelby) were used to recover sandy and silty clay samples from a Holocene lagoon deposit. Sample quality is established on oedometric specimens using normalized void ratio change on reconsolidation, comparisons of laboratory and field shear wave velocity and the ratio of suction to vertical « In situ » effective stress. Normalized void ratio change and shear wave based criteria are in agreement, and more so if the laboratory measurements are taken just after resaturation. The ratio of suction to normalised vertical effective stress shows no clear relation with normalized void ratio change., The research reported here was partly supported by the Spanish Ministry of Science (TRA2009_0076) and FEDER.
Recercat. Dipósit de la Recerca de Catalunya
Publicación Contribución de congreso (ConferenceOutput)

Sample quality examination on silty soils, Qualité des echantillons dans sols limoneux

  • Arroyo Álvarez de Toledo, Marcos
  • Pineda Jiménez, Jubert Andrés
  • Sau Valenzuela, Núria
  • Devincenzi, M.J.
  • Pérez, N.
Mediterranean deltaic environments typically produce soil deposits in which silts dominate, granular intercalations are frequent and the mineralogy includes an important carbonate fraction. One question still open is what sampling methods are most appropriate to recover undisturbed samples from these deposits and how best to evaluate disturbance on samples recovered from them. In this paper we present results from a testing campaign on silty deposits in which several sampling methods (Sherbrooke, Osterberg, Shelby) were used to recover sandy and silty clay samples from a Holocene lagoon deposit. Sample quality is established on oedometric specimens using normalized void ratio change on reconsolidation, comparisons of laboratory and field shear wave velocity and the ratio of suction to vertical « In situ » effective stress. Normalized void ratio change and shear wave based criteria are in agreement, and more so if the laboratory measurements are taken just after resaturation. The ratio of suction to normalised vertical effective stress shows no clear relation with normalized void ratio change., The research reported here was partly supported by the Spanish Ministry of Science (TRA2009_0076) and FEDER., Postprint (published version)
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Karyotypic complexity rather than chromosome 8 abnormalities aggravates the outcome of chronic lymphocytic leukemia patients with TP53 aberrations

  • Blanco, Gonzalo|||0000-0001-6557-3764
  • Puiggros, Anna|||0000-0001-9627-4978
  • Baliakas, Panagiotis|||0000-0002-5634-7156
  • Athanasiadou, Anastasia
  • García-Malo, MaDolores
  • Collado, Rosa|||0000-0002-8205-6192
  • Xochelli, Aliki
  • Rodríguez-Rivera, María
  • Ortega, Margarita
  • Calasanz, M.J.|||0000-0002-0374-3008
  • Luño, Elisa
  • Vargas, MªTeresa
  • Grau Cat, Javier
  • Martínez-Laperche, Carolina
  • Valiente, Alberto
  • Cervera, José|||0000-0001-8252-1106
  • Anagnostopoulos, Achilles|||0000-0003-4384-9031
  • Gimeno, Eva|||0000-0002-3534-6189
  • Abella Monreal, Eugenia|||0000-0001-9605-8458
  • Stalika, Evangelia
  • Hernández Rivas, Jesús María|||0000-0002-9661-9371
  • Ortuño, Francisco José|||0000-0003-4450-9346
  • Robles, Diego
  • Ferrer, Ana Maria|||0000-0002-3381-9472
  • Ivars, David
  • González, Marcos
  • Bosch Albareda, Francesc|||0000-0001-9241-2886
  • Abrisqueta, Pau|||0000-0001-9625-7422
  • Stamatopoulos, Kostas|||0000-0001-8529-640X
  • Espinet Solà, Blanca|||0000-0002-4294-8145
Patients with chronic lymphocytic leukemia (CLL) harboring TP53 aberrations (TP53 abs; chromosome 17p deletion and/or TP53 mutation) exhibit an unfavorable clinical outcome. Chromosome 8 abnormalities, namely losses of 8p (8p-) and gains of 8q (8q+) have been suggested to aggravate the outcome of patients with TP53 abs. However, the reported series were small, thus hindering definitive conclusions. To gain insight into this issue, we assessed a series of 101 CLL patients harboring TP53 disruption. The frequency of 8p- and 8q+ was 14.7% and 17.8% respectively. Both were associated with a significantly (P < 0.05) higher incidence of a complex karyotype (CK, ≥3 abnormalities) detected by chromosome banding analysis (CBA) compared to cases with normal 8p (N-8p) and 8q (N-8q), respectively. In univariate analysis for 10-year overall survival (OS), 8p- (P = 0.002), 8q+ (P = 0.012) and CK (P = 0.009) were associated with shorter OS. However, in multivariate analysis only CK (HR = 2.47, P = 0.027) maintained independent significance, being associated with a dismal outcome regardless of chromosome 8 abnormalities. In conclusion, our results highlight the association of chromosome 8 abnormalities with CK amongst CLL patients with TP53 abs, while also revealing that CK can further aggravate the prognosis of this aggressive subgroup.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MicroRNA-200, associated with metastatic breast cancer, promotes traits of mammary luminal progenitor cells

  • Sánchez-Cid, Lourdes
  • Pons, Mònica
  • Lozano, Juan José
  • Rubio, Nuria
  • Guerra-Rebollo, Marta
  • Soriano, Aroa|||0000-0001-9659-1471
  • Paris-Coderch, Laia
  • Segura, Miquel F.
  • Fueyo Arévalo, Raquel
  • Arguimbau, Judit
  • Zodda, Erika
  • Bermudo, Raquel
  • Alonso, Immaculada
  • Caparrós, Xavier
  • Cascante, Marta
  • Rafii, Arash
  • Kang, Yibin
  • Martínez-Balbás, Marian
  • Weiss, Stephen J.
  • Blanco Fernández, Jerónimo
  • Muñoz, Montserrat
  • Fernández, Pedro Luis|||0000-0002-8618-4597
  • Thomson, Timothy M.
MicroRNAs are critical regulators of gene networks in normal and abnormal biological processes. Focusing on invasive ductal breast cancer (IDC), we have found dysregulated expression in tumor samples of several microRNAs, including the miR-200 family, along progression from primary tumors to distant metastases, further reflected in higher blood levels of miR-200b and miR-7 in IDC patients with regional or distant metastases relative to patients with primary node-negative tumors. Forced expression of miR-200s in MCF10CA1h mammary cells induced an enhanced epithelial program, aldehyde dehydrogenase (ALDH) activity, mammosphere growth and ability to form branched tubuloalveolar structures while promoting orthotopic tumor growth and lung colonization in vivo. MiR-200s also induced the constitutive activation of the PI3K-Akt signaling through downregulation of PTEN, and the enhanced mammosphere growth and ALDH activity induced in MCF10CA1h cells by miR-200s required the activation of this signaling pathway. Interestingly, the morphology of tumors formed in vivo by cells expressing miR-200s was reminiscent of metaplastic breast cancer (MBC). Indeed, the epithelial components of MBC samples expressed significantly higher levels of miR-200s than their mesenchymal components and displayed a marker profile compatible with luminal progenitor cells. We propose that microRNAs of the miR-200 family promote traits of highly proliferative breast luminal progenitor cells, thereby exacerbating the growth and metastatic properties of transformed mammary epithelial cells.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Mn₃O₄@CoMn₂O₄-CoₓOy nanoparticles, Partial cation exchange synthesis and electrocatalytic properties toward the oxygen reduction and evolution reactions

  • Luo, Zhishan|||0000-0002-0801-9238
  • Irtem, Erdem
  • Ibáñez, Maria|||0000-0001-5013-2843
  • Nafria, Raquel|||0000-0002-3254-1616
  • Martí-Sánchez, Sara|||0000-0003-4283-1489
  • Genç, Aziz|||0000-0002-2888-2549
  • De La Mata, Maria|||0000-0002-1581-4838
  • Liu, Yu|||0000-0001-7313-6740
  • Cadavid, Doris|||0000-0002-1376-6078
  • Llorca, Jordi|||0000-0002-7447-9582
  • Arbiol i Cobos, Jordi|||0000-0002-0695-1726
  • Andreu, Teresa|||0000-0002-2804-4545
  • Morante, Joan Ramon|||0000-0002-4981-4633
  • Cabot i Codina, Andreu|||0000-0002-7533-3251
Mn₃O₄@CoMn₂O₄ nanoparticles (NPs) were produced at low temperature and ambient atmosphere using a one-pot two-step synthesis protocol involving the cation exchange of Mn by Co in preformed Mn₃O₄ NPs. Selecting the proper cobalt precursor, the nucleation of CoₓOy crystallites at the Mn₃O₄@CoMn₂O₄ surface could be simultaneously promoted to form Mn₃O₄@CoMn₂O₄-CoₓOy NPs. Such heterostructured NPs were investigated for oxygen reduction and evolution reactions (ORR, OER) in alkaline solution. Mn₃O₄@CoMn₂O₄-CoₓOy NPs with [Co]/[Mn] = 1 showed low overpotentials of 0.31 V at -3 mA·cm-2 and a small Tafel slope of 52 mV·dec-1 for ORR, and overpotentials of 0.31 V at 10 mA·cm-2 and a Tafel slope of 81 mV·dec-1 for OER, thus outperforming commercial Pt-, IrO2-based and previously reported transition metal oxides. This cation-exchange-based synthesis protocol opens up a new approach to design novel heterostructured NPs as efficient nonprecious metal bifunctional oxygen catalysts.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Exposure to disinfection by-products in swimming pools and biomarkers of genotoxicity and respiratory damage - The PISCINA2 Study

  • Font Ribera, Laia|||0000-0001-8447-4905
  • Marco, Esther
  • Grimalt, Joan|||0000-0002-7391-5768
  • Pastor Benito, Susana|||0000-0003-2454-5163
  • Marcos, Ricard|||0000-0001-7891-357X
  • Abramsson-Zetterberg, Lilianne
  • Pedersen, Marie
  • Grummt, Tamara
  • Junek, Ralf
  • Barreiro, Esther|||0000-0003-2708-3443
  • Heederik, Dick
  • Spithoven, Jack
  • Critelli, Rossana
  • Naccarati, Alessio
  • Schmalz, Christina
  • Zwiener, Christian
  • Liu, Jiaqi
  • Zhang, Xiangru
  • Mitch, William
  • Gracia-Lavedan, Esther
  • Arjona, Lourdes
  • De Bont, Jeroen|||0000-0001-9924-5961
  • Tarès, Lluïsa
  • Vineis, Paolo
  • Kogevinas, Manolis|||0000-0002-9605-0461
  • Villanueva, Cristina|||0000-0002-0783-1259
Background: Swimming in pools is a healthy activity that entails exposure to disinfection by-products (DBPs), some of which are irritant and genotoxic. Objectives: We evaluated exposure to DBPs during swimming in a chlorinated pool and the association with short-term changes in genotoxicity and lung epithelium permeability biomarkers. Methods: Non-smoker adults (N = 116) swimming 40 min in an indoor pool were included. We measured a range of biomarkers before and at different times after swimming: trihalomethanes (THMs) in exhaled breath (5 min), trichloroacetic acid (TCAA) in urine (30 min), micronuclei in lymphocytes (1 h), serum club cell protein (CC16) (1 h), urine mutagenicity (2 h) and micronuclei in reticulocytes (4 days in a subset, N = 19). Several DBPs in water and trichloramine in air were measured, and physical activity was extensively assessed. We estimated interactions with polymorphisms in genes related to DBP metabolism. Results: Median level of chloroform, brominated and total THMs in water was 37.3, 9.5 and 48.5, μg/L, respectively, and trichloramine in air was 472.6 μg/m. Median exhaled chloroform, brominated and total THMs increased after swimming by 10.9, 2.6 and 13.4, μg/m, respectively. Creatinine-adjusted urinary TCAA increased by 3.1 μmol/mol. Micronuclei in lymphocytes and reticulocytes, urine mutagenicity and serum CC16 levels remained unchanged after swimming. Spearman correlation coefficients showed no association between DBP exposure and micronuclei in lymphocytes, urine mutagenicity and CC16. Moderate associations were observed for micronuclei in reticulocytes and DBP exposure. Conclusions: The unchanged levels of the short-term effect biomarkers after swimming and null associations with personal estimates of exposure to DBPs suggest no measurable effect on genotoxicity in lymphocytes, urine mutagenicity and lung epithelium permeability at the observed exposure levels. The moderate associations with micronuclei in reticulocytes require cautious interpretation given the reduced sample size.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Diagnostic accuracy of non-melanocytic pink flat skin lesions on the legs, Dermoscopic and reflectance confocal microscopy evaluation

  • Gómez Martín, Ignacio
  • Moreno Fernández, Sara
  • Duran-Jordà, Xavier|||0000-0001-8517-9254
  • Pujol Vallverdú, Ramón M.|||0000-0002-5622-6055
  • Segura, Sonia|||0000-0003-0653-1382
Pink flat skin lesions on the legs in elderly people represent a diagnostic challenge due to the paucity of clinical and dermoscopic evidence. A prospective study of 114 pink flat lesions on the legs of 85 elderly patients was performed to describe the utility of reflectance confocal microscopy in this clinical context. Evaluation of clinical, dermoscopic and confocal parameters and calculation of diagnostic accuracy/sensi-tivity/specificity for non-melanoma skin cancer diagnosis of each technique were carried out. Thirty-four benign and 80 malignant neoplasms were analysed. A correct clinical diagnosis was established in 49.1% of cases (sensitivity 68.7%, specificity 73.5%). Dermoscopy achieved 59.6% correct diagnosis (sensiti-vity 85%, specificity 67.6%) and confocal microscopy evaluation after clinical and dermoscopic evaluation rendered a correct diagnosis in 85.1% of cases (sensi-tivity 97.5%, specificity 88.2%). Confocal microscopy may improve diagnostic accuracy, sensitivity and specificity as a secondary evaluation after dermoscopy. A diagnostic confocal algorithm for pink flat lesions on the legs is proposed.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

APOA1 oxidation is associated to dysfunctional high-density lipoproteins in human abdominal aortic aneurysm

  • Martínez-López, Diego
  • Camafeita, Emilio|||0000-0002-4577-5331
  • Cedó, Lídia|||0000-0003-4354-3411
  • Roldán-Montero, Raquel|||0000-0003-0117-2608
  • Jorge, Inmaculada
  • García-Marqués, Fernando
  • Gómez-Serrano, María
  • Bonzon-Kulichenko, Elena|||0000-0003-0852-7520
  • Blanco Vaca, Francisco|||0000-0001-7380-5385
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Michel, Jean-Baptiste
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Martin-Ventura, Jose Luis
High-density lipoproteins (HDL) are a complex mixture of lipids and proteins with vasculoprotective properties. However, HDL components could suffer post-translational modifications (PTMs) under pathological conditions, leading to dysfunctional HDL. We studied whether HDL are modified in abdominal aortic aneurysm (AAA) and the effect on HDL functionality. HDL were isolated by ultracentrifugation from AAA tissue (HDL-T) and from plasma of healthy volunteers and then incubated with AAA tissue-conditioned medium (HDL-AAA CM). PTMs from these particles were characterized using Comet-PTM. The ability of HDL-AAA CM for promoting cholesterol efflux was determined ex vivo and in vivo by using J774A.1 [ 3 H]cholesterol-labeled mouse macrophages and after injecting [ 3 H]cholesterol-labeled mouse macrophages and HDL into the peritoneal cavity of wild-type C57BL/6 mice, respectively. Trp50 and Trp108 oxidized forms of APOA1 in HDL incubated with conditioned-medium of activated neutrophils and in plasma of AAA patients and controls were measured by targeted parallel reaction monitoring. Oxidation was the most prevalent PTM in apolipoproteins, particularly in APOA1. Trp50 and Trp108 in APOA1 were the residues most clearly affected by oxidation in HDL-T and in HDL-AAA CM, when compared to their controls. In addition, cholesterol efflux was decreased in macrophages incubated with HDL-AAA CM in vitro and a decreased macrophage-to-serum reverse cholesterol transport was also observed in mice injected with HDL-AAA CM. Finally, both oxidized Trp50 and Trp108 forms of APOA1 were increased in HDL incubated with conditioned-medium of activated neutrophils and in plasma of AAA patients in relation to controls. Oxidative modifications of HDL present in AAA tissue and plasma were closely associated with the loss of vasculoprotective properties of HDL in AAA. MINECO, ISCiii-FEDER, CIBERDEM, CIBERCV and LA CAIXA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MiR-204 silencing in intraepithelial to invasive cutaneous squamous cell carcinoma progression

  • Toll Abelló, Agustí|||0000-0003-2656-0076
  • Salgado Sánchez, Rocío Nieves|||0000-0003-1678-8982
  • Espinet Solà, Blanca|||0000-0002-4294-8145
  • Diaz-Lagares, Angel|||0000-0002-9114-9227
  • Hernández-Ruiz, Eugenia
  • Andrades, Evelyn|||0000-0003-2166-6760
  • Sandoval, Juan|||0000-0002-5100-973X
  • Esteller, M.|||0000-0003-4490-6093
  • Pujol, Ramón M..
  • Hernández-Muñoz, Inmaculada
Cutaneous squamous cell carcinoma (cSCC) is the second most common skin cancer and frequently progresses from an actinic keratosis (AK), a sun-induced keratinocyte intraepithelial neoplasia (KIN). Epigenetic mechanisms involved in the phenomenon of progression from AK to cSCC remain to be elicited. Expression of microRNAs in sun-exposed skin, AK and cSCC was analysed by Agilent microarrays. DNA methylation of miR-204 promoter was determined by bisulphite treatment and pyrosequencing. Identification of miR-204 targets and pathways was accomplished in HaCat cells. Immunofluorescence and immunohistochemistry were used to analyze STAT3 activation and PTPN11 expression in human biopsies. cSCCs display a marked downregulation of miR-204 expression when compared to AK. DNA methylation of miR-204 promoter was identified as one of the repressive mechanisms that accounts for miR-204 silencing in cSCC. In HaCaT cells miR-204 inhibits STAT3 and favours the MAPK signaling pathway, likely acting through PTPN11, a nuclear tyrosine phosphatase that is a direct miR-204 target. In non-peritumoral AK lesions, activated STAT3, as detected by pY705-STAT3 immunofluorescence, is retained in the membrane and cytoplasm compartments, whereas AK lesions adjacent to cSCCs display activated STAT3 in the nuclei. Our data suggest that miR-204 may act as a "rheostat" that controls the signalling towards the MAPK pathway or the STAT3 pathway in the progression from AK to cSCC. The online version of this article (doi:10.1186/s12943-016-0537-z) contains supplementary material, which is available to authorized users.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

MicroRNA-1291 Is Associated With Locoregional Metastases in Patients With Early-Stage Breast Cancer

  • Escuin i Borràs, Daniel|||0000-0003-3538-0579
  • López Vilaró, Laura|||0000-0002-5428-8017
  • Bell, Olga|||0009-0000-2858-6187
  • Mora Brugués, Josefina|||0000-0001-6777-5132
  • Moral, Antonio|||0000-0001-5551-0145
  • Pérez, José Ignacio
  • Arqueros, Cristina|||0000-0003-1249-2324
  • Ramon y Cajal, Teresa|||0000-0003-3490-3585
  • Lerma Puertas, Enrique|||0000-0001-7908-2747
  • Barnadas i Molins, Agustí|||0000-0002-0429-1349
Evidence that microRNAs (miRNAs) regulate the various steps of metastasis is increasing. Several studies have looked at the miRNA expression profile in primary breast tumors but few have compared primary tumor and sentinel lymph node (SLN) metastasis. We correlated the expression of miRNAs with the SLN status and the outcome of axillary lymph node dissection (ALND) in 60 patients with early breast cancer. We profiled the expression of miRNAs in paired breast tumor samples and SLNs using the NextSeq500 Illumina platform and key findings were validated by qPCR. MultiMiR Bioconductor and Reactome pathways analysis were performed to identify target genes and signaling pathways affected by altered expressed miRNAs. Our results show that nine miRNAs were differentially expressed in tumor tissues (q ≤ 0.05). In tumor samples, a 13.5-fold up-regulation of miR-7641-2 (q < 0.001) and a 2.9-fold down-regulation of miR-1291 (q < 0.001) were associated with tumors with positive SLNs. However, only down-regulation of miR-1291 (q = 0.048) remained significant in paired SLNs samples. Interestingly, a 10.5 up-regulation of miR-1291 in SLNs samples was associated with additional axillary lymph node involvement (q < 0.001). The enrichment analyses showed that canonical and non-canonical WNT pathways and negative regulation of various receptor tyrosine kinases signaling pathways were targets of miR-1291 and supports the role of miR-1291 as a tumor suppressor gene (TSG). Further studies are warranted to investigate the use of miR-1291 as a surrogate biomarker of SLN node metastasis in patients with early-stage breast cancer.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Phosphorylation of eIF4E Confers Resistance to Cellular Stress and DNA-Damaging Agents through an Interaction with 4E-T, A Rationale for Novel Therapeutic Approaches

  • Martínez, Alba
  • Sesé, Marta|||0000-0003-1473-4833
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Robichaud, Nathaniel
  • Sonenberg, Nahum
  • Aasen, Trond|||0000-0003-0763-2695
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Phosphorylation of the eukaryotic translation initiation factor eIF4E is associated with malignant progression and poor cancer prognosis. Accordingly, here we have analyzed the association between eIF4E phosphorylation and cellular resistance to oxidative stress, starvation, and DNA-damaging agents in vitro. Using immortalized and cancer cell lines, retroviral expression of a phosphomimetic (S209D) form of eIF4E, but not phospho-dead (S209A) eIF4E or GFP control, significantly increased cellular resistance to stress induced by DNA-damaging agents (cisplatin), starvation (glucose+glutamine withdrawal), and oxidative stress (arsenite). De novo accumulation of eIF4E-containing cytoplasmic bodies colocalizing with the eIF4E-binding protein 4E-T was observed after expression of phosphomimetic S209D, but not S209A or wild-type eIF4E. Increased resistance to cellular stress induced by eIF4E-S209D was lost upon knockdown of endogenous 4E-T or use of an eIF4E-W73A-S209D mutant unable to bind 4E-T. Cancer cells treated with the Mnk1/2 inhibitor CGP57380 to prevent eIF4E phosphorylation and mouse embryonic fibroblasts derived from Mnk1/2 knockout mice were also more sensitive to arsenite and cisplatin treatment. Polysome analysis revealed an 80S peak 2 hours after arsenite treatment in cells overexpressing phosphomimetic eIF4E, indicating translational stalling. Nonetheless, a selective increase was observed in the synthesis of some proteins (cyclin D1, HuR, and Mcl-1). We conclude that phosphorylation of eIF4E confers resistance to various cell stressors and that a direct interaction or regulation of 4E-T by eIF4E is required. Further delineation of this process may identify novel therapeutic avenues for cancer treatment, and these results support the use of modern Mnk1/2 inhibitors in conjunction with standard therapy.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

HPV Testing by cobas HPV Test in a Population from Catalonia

  • Lloveras, Belen|||0000-0001-8659-5241
  • Gomez, Silvia
  • Alameda, Francesc|||0000-0002-7302-6901
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • Mojal, Sergi|||0000-0003-0523-3869
  • Muset, Mercè
  • Parra, Manuel
  • Palomares, José Carlos
  • Serrano, Sergi
HPV testing in cervical cancer screening has been proposed as an alternative or complementary to cytology in women older than 30 years. However, adequate clinical sensitivity and specificity are crucial for a new test to be implemented. Hybrid Capture 2 (HC2) has proved good clinical performance in selecting women at risk for high-grade intraepithelial lesions with a high sensitivity and specificity. cobas HPV Test has been recently launched and its performance in different clinical settings needs to be determined. The aim of this study was to evaluate the cobas HPV Test for the detection of cervical HPV infection in a population of women in Catalonia (Spain) using HC2 as a reference. Cervical liquid cytology samples from 958 women have been studied. Sensitivity was analyzed in 60 samples from patients with a high-grade intraepithelial lesion (≥CIN2) on histology and specificity was determined in 898 samples from women with no ≥CIN2. All cases had HC2 and cobas HPV Test performed. Statistical analyses of sensitivity, specificity and comparison between HC2 and cobas HPV Test by a non-inferiority test were applied. Sensitivity of HC2 and cobas HPV Test for detecting ≥CIN2 proved identical (98.3%) while specificity was 85.3% and 86.2% respectively. The non-inferiority test demonstrated that cobas HPV Test surpassed 90% sensitivity and 98% specificity of HC2. The cobas HPV Test results fulfilled sensitivity and specificity requirements for HPV based cervical cancer screening and for the triage of minor cytological abnormalities, allowing its introduction in clinical settings.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm

  • Roldán-Montero, Raquel|||0000-0003-0117-2608
  • Pérez-Sáez, Juan M.|||0000-0002-6722-5760
  • Cerro-Pardo, Isabel|||0000-0002-2542-5051
  • Oller Pedrosa, Jorge|||0000-0002-2224-2954
  • Martínez-López, Diego
  • Nuñez, Estefania|||0000-0002-0876-1264
  • Maller, Sebastian M.|||0000-0001-5536-7596
  • Gutiérrez Muñoz, Carmen|||0000-0001-8975-6135
  • Mendez-Barbero, Nerea|||0000-0003-1620-3067
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Michel, Jean-Baptiste
  • Mittelbrunn, Maria|||0000-0003-3487-8762
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Rabinovich, Gabriel A.|||0000-0002-0947-8735
  • Martin-Ventura, Jose L.|||0000-0003-2090-8641
Pathological vascular remodeling is the underlying cause of atherosclerosis and abdominal aortic aneurysm (AAA). Here, we analyzed the role of galectin-1 (Gal-1), a β-galactoside-binding protein, as a therapeutic target for atherosclerosis and AAA. Mice lacking Gal-1 (Lgals1 -/- ) developed severe atherosclerosis induced by pAAV/D377Y-mPCSK9 adenovirus and displayed higher lipid levels and lower expression of contractile markers of vascular smooth muscle cells (VSMCs) in plaques than wild-type mice. Proteomic analysis of Lgals1 -/- aortas showed changes in markers of VSMC phenotypic switch and altered composition of mitochondrial proteins. Mechanistically, Gal-1 silencing resulted in increased foam cell formation and mitochondrial dysfunction in VSMCs, while treatment with recombinant Gal-1 (rGal-1) prevented these effects. Furthermore, rGal-1 treatment attenuated atherosclerosis and elastase-induced AAA, leading to higher contractile VSMCs in aortic tissues. Gal-1 expression decreased in human atheroma and AAA compared to control tissue. Thus, Gal-1-driven circuits emerge as potential therapeutic strategies in atherosclerosis and AAA. Galectin-1 plays an essential role in prevention of atherosclerosis and abdominal aortic aneurysm.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Malondialdehyde-modified HDL particles elicit a specific IgG response in abdominal aortic aneurysm

  • Rodríguez-Carrio, J.
  • Cerro-Pardo, Isabel|||0000-0002-2542-5051
  • Lindholt, Jes S.|||0000-0001-9536-4488
  • Bonzon-Kulichenko, Elena|||0000-0003-0852-7520
  • Martínez-López, Diego
  • Roldán-Montero, R.
  • Escolà-Gil, Joan Carles|||0000-0001-9021-2485
  • Michel, J.B.
  • Blanco-Colio, Luis Miguel|||0000-0002-1560-6609
  • Vázquez, Jesús|||0000-0003-1461-5092
  • Suárez, A.
  • Martín-Ventura, J.L.
High Density Lipoprotein (HDL) plays a protective role in abdominal aortic aneurysm (AAA); however, recent findings suggest that oxidative modifications could lead to dysfunctional HDL in AAA. This study aimed at testing the effect of oxidized HDL on aortic lesions and humoral immune responses in a mouse model of AAA induced by elastase, and evaluating whether antibodies against modified HDL can be found in AAA patients. HDL particles were oxidized with malondialdehyde (HDL-MDA) and the changes were studied by biochemical and proteomics approaches. Experimental AAA was induced in mice by elastase perfusion and then mice were treated with HDL-MDA, HDL or vehicle for 14 days. Aortic lesions were studied by histomorphometric analysis. Levels of anti-HDL-MDA IgG antibodies were measured by an in-house immunoassay in the mouse model, in human tissue-supernatants and in plasma samples from the VIVA cohort. HDL oxidation with MDA was confirmed by enhanced susceptibility to diene formation. Proteomics demonstrated the presence of MDA adducts on Lysine residues of HDL proteins, mainly ApoA-I. MDA-modification of HDL abrogated the protective effect of HDL on cultured endothelial cells as well as on AAA dilation in mice. Exposure to HDL-MDA elicited an anti-HDL-MDA IgG response in mice. Anti-HDL-MDA were also detected in tissue-conditioned media from AAA patients, mainly in intraluminal thrombus. Higher plasma levels of anti-HDL-MDA IgG antibodies were found in AAA patients compared to controls. Anti-HDL-MDA levels were associated with smoking and were independent predictors of overall mortality in AAA patients. Overall, MDA-oxidized HDL trigger a specific humoral immune response in mice. Besides, antibodies against HDL-MDA can be detected in tissue and plasma of AAA patients, suggesting its potential use as surrogate stable biomarkers of oxidative stress in AAA.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

p53 wild-type colorectal cancer cells that express a fetal gene signature are associated with metastasis and poor prognosis

  • Solé Font, Laura|||0000-0002-3195-0565
  • Lobo-Jarne, Teresa|||0000-0002-1632-438X
  • Álvarez-Villanueva, Daniel
  • Alonso-Marañón, Josune
  • Guillén, Yolanda|||0000-0001-8673-6470
  • Guix, Marta|||0000-0002-2143-0697
  • Sangrador, Irene
  • Rozalén, Catalina
  • Vert, Anna
  • Barbachano, Antonio|||0000-0002-1248-5143
  • Lop Gros, Joan|||0000-0002-9442-5688
  • Salido, Marta|||0000-0001-9988-5977
  • Bellosillo Paricio, Beatriz|||0000-0002-5335-2726
  • García-Romero, Raquel
  • Garrido, Marta
  • González Miranda, Jessica|||0000-0001-7732-1564
  • Martínez-Iniesta, María
  • López-Arribillaga, Erika|||0000-0002-9451-6635
  • Salazar, Ramón
  • Torres, Ferran|||0000-0002-7355-7913
  • Iglesias, Mar|||0000-0002-2274-4671
  • Celià-Terrassa, Toni|||0000-0002-0615-8744
  • Muñoz, Alberto|||0000-0003-3890-4251
  • Villanueva, Alejandro|||0000-0001-5164-0006
  • Bigas Salvans, Anna|||0000-0003-4801-6899
  • Espinosa, Lluis|||0000-0002-2897-4099
Current therapy against colorectal cancer (CRC) is based on DNA-damaging agents that remain ineffective in a proportion of patients. Whether and how non-curative DNA damage-based treatment affects tumor cell behavior and patient outcome is primarily unstudied. Using CRC patient-derived organoids (PDO)s, we show that sublethal doses of chemotherapy (CT) does not select previously resistant tumor populations but induces a quiescent state specifically to TP53 wildtype (WT) cancer cells, which is linked to the acquisition of a YAP1-dependent fetal phenotype. Cells displaying this phenotype exhibit high tumor-initiating and metastatic activity. Nuclear YAP1 and fetal traits are present in a proportion of tumors at diagnosis and predict poor prognosis in patients carrying TP53 WT CRC tumors. We provide data indicating the higher efficacy of CT together with YAP1 inhibitors for eradication of therapy resistant TP53 WT cancer cells. Together these results identify fetal conversion as a useful biomarker for patient prognosis and therapy prescription.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Evidence in chronic kidney disease-mineral and bone disorder guidelines, Is it time to treat or time to wait?

  • Bover, Jordi|||0000-0003-3577-2273
  • Ureña-Torres, Pablo|||0000-0001-6757-1906
  • Mateu, Silvia
  • DaSilva Santos, Iara|||0000-0001-8203-6135
  • Gràcia, Silvia
  • Sánchez-Baya, Maya|||0000-0003-1689-9383
  • Arana Aliaga, Carolt|||0000-0003-1100-5758
  • Fayos de Arizón, Leonor|||0000-0002-9277-645X
  • Guirado, Luis|||0000-0001-5119-3912
  • Cozzolino, Mario|||0000-0002-8494-6252
Chronic kidney disease-mineral and bone disorder (CKD-MBD) is one of the many important complications associated with CKD and may at least partially explain the extremely high morbidity and mortality among CKD patients. The 2009 Kidney Disease: Improving Global Outcomes (KDIGO) Clinical Practice Guideline document was based on the best information available at that time and was designed not only to provide information but also to assist in decision-making. In addition to the international KDIGO Work Group, which included worldwide experts, an independent Evidence Review Team was assembled to ensure rigorous review and grading of the existing evidence. Based on the evidence from new clinical trials, an updated Clinical Practice Guideline was published in 2017. In this review, we focus on the conceptual and practical evolution of clinical guidelines (from eMinence-based medicine to eVidence-based medicine and 'living' guidelines), highlight some of the current important CKD-MBD-related changes, and underline the poor or extremely poor level of evidence present in those guidelines (as well as in other areas of nephrology). Finally, we emphasize the importance of individualization of treatments and shared decision-making (based on important ethical considerations and the 'best available evidence'), which may prove useful in the face of the uncertainty over the decision whether 'to treat' or 'to wait'.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

A saturated map of common genetic variants associated with human height

  • Yengo, Loic|||0000-0002-4272-9305
  • Vedantam, Sailaja|||0000-0003-3892-7461
  • Marouli, Eirini|||0000-0001-6179-1609
  • Sidorenko, Julia
  • Bartell, Eric
  • Sakaue, Saori|||0000-0003-3618-9717
  • Graff, Marielisa
  • Eliasen, Anders U.
  • Jiang, Yunxuan
  • Raghavan, Sridharan
  • Miao, Jenkai
  • Arias, Joshua D.
  • Graham, Sarah E.|||0000-0003-1271-2489
  • Mukamel, Ronen E.
  • Spracklen, Cassandra N.|||0000-0003-3590-7182
  • Yin, Xianyong|||0000-0001-6454-2384
  • Chen, Shyh-Huei
  • Ferreira, Teresa
  • Highland, Heather H.
  • Ji, Yingjie
  • Karaderi, Tugce|||0000-0001-9763-8139
  • Lin, Kuang
  • Lüll, Kreete
  • Malden, Deborah|||0000-0003-0567-8294
  • Medina-Gomez, Carolina|||0000-0001-7999-5538
  • Machado, Moara
  • Moore, Amy
  • Rüeger, Sina
  • Sim, Xueling|||0000-0002-1233-7642
  • Vrieze, Scott
  • Ahluwalia, Tarunveer Singh|||0000-0002-7464-3354
  • Akiyama, Masato|||0000-0002-1879-5476
  • Allison, Matthew A.
  • Álvarez, Marcus
  • Andersen, Mette korre|||0000-0001-8227-1469
  • Ani, Alireza|||0000-0002-7868-3118
  • Appadurai, Vivek
  • Arbeeva, Liubov|||0000-0001-5004-419X
  • Bhaskar, Seema
  • Bielak, Lawrence F.|||0000-0002-3443-8030
  • Bollepalli, Sailalitha|||0000-0002-8773-7149
  • Bonnycastle, Lori L.
  • Bork-Jensen, Jette
  • Bradfield, Jonathan Paul|||0000-0001-8758-2071
  • Bradford, Yuki
  • Braund, Peter S.|||0000-0001-8540-5709
  • Brody, Jennifer A.|||0000-0001-8509-148X
  • Burgdorf, Kristoffer S.
  • Cade, Brian E.|||0000-0003-1424-0673
  • Cai, H.
  • Cai, Qiuyin
  • Campbell, Archie|||0000-0003-0198-5078
  • Cañadas-Garre, Marisa|||0000-0003-1103-5658
  • Catamo, Eulalia|||0000-0002-4701-9134
  • Chai, Jin-Fang|||0000-0003-3770-1137
  • Chai, Xiaoran
  • Chang, Liching
  • Chang, Yicheng
  • Chen, Chien Hsiun
  • Chesi, Alessandra|||0000-0002-0954-7446
  • Choi, Seunghoan
  • Chung, Renhua
  • Cocca, Massimiliano|||0000-0002-1127-7596
  • Concas, Maria Pina|||0000-0003-3598-2537
  • Couture, Christian Y.
  • Cuellar-Partida, Gabriel|||0000-0001-7648-4097
  • Danning, Rebecca D.
  • Daw, E. Warwick
  • Degenhard, Frauke
  • Delgado, Graciela E.|||0000-0002-1272-7210
  • Delitala, Alessandro|||0000-0003-1729-8969
  • Demirkan, Ayşe|||0000-0002-7546-0867
  • Deng, Xuan|||0000-0003-0918-817X
  • Devineni, Poornima
  • Dietl, Alexander|||0000-0002-4091-8620
  • Dimitriou, Maria E.
  • Dimitrov, Latchezar M.
  • Dorajoo, Rajkumar|||0000-0001-6608-2051
  • Ekici, Arif B.
  • Engmann, Jorgen|||0000-0001-7015-7773
  • Fairhurst-Hunter, Zammy
  • Farmaki, Aliki Eleni
  • Faul, Jessica D.|||0000-0002-6969-6478
  • Fernandez-Lopez, Juan Carlos|||0000-0003-3680-4193
  • Forer, Lukas|||0000-0003-2139-7329
  • Francescatto, Margherita
  • Freitag-Wolf, Sandra
  • Fuchsberger, Christian|||0000-0002-5918-8947
  • Galesloot, Tessel E.
  • Gao, Yan
  • Gao, Zishan|||0000-0003-1299-0286
  • Geller, Frank
  • Giannakopoulou, Olga
  • Giulianini, Franco
  • Gjesing, Anette Prior
  • Goel, Anuj|||0000-0003-2307-4021
  • Gordon, Scott D.|||0000-0001-7623-328X
  • Gorski, Mathias M.
  • Grove, Jakob|||0000-0003-2284-5744
  • Guo, Xiuqing
  • Gustafsson, S.|||0000-0001-5894-0351
  • Haessler, Jeffrey W.
  • Hansen, Thomas Folkmann
  • Havulinna, Aki Samuli
  • Haworth, S.J.
  • He, Jing
  • Heard-Costa, Nancy L.
  • Hebbar, Prashantha|||0000-0001-6560-7063
  • Hindy, George|||0000-0002-7257-9299
  • Ho, Yuk Lam Anne
  • Hofer, Edith
  • Holliday, Elizabeth|||0000-0002-4066-6224
  • Horn, Katrin
  • Hornsby, Whitney E.
  • Hottenga, Jouke Jan|||0000-0002-5668-2368
  • Huang, Hongyan
  • Huang, Jie
  • Huerta-Chagoya, Alicia|||0000-0001-6218-3904
  • Huffman, Jennifer E.|||0000-0002-9672-2491
  • Hung, Yijen
  • Huo, Shaofeng
  • Hwang, Mi-yeong
  • Iha, Hiroyuki|||0000-0003-4261-2067
  • Ikeda, Daisuke D.|||0000-0001-8403-0327
  • Isono, Masato
  • Jackson, Anne U.|||0000-0002-9672-2547
  • Jäger, Susanne
  • Jansen, Iris E.|||0000-0003-1901-8131
  • Johansson, Ingegerd
  • Jonas, Jost Bruno
  • Jonsson, Anna Elisabet
  • Jørgensen, Torben J.
  • Kalafati, IP.|||0000-0001-5572-7491
  • Kanai, Masahiro|||0000-0001-5165-4408
  • Kanoni, Stavroula|||0000-0002-1691-9615
  • Kårhus, Line Lund
  • Kasturiratne, Anuradhani
  • Katsuya, Tomohiro|||0000-0002-8892-8828
  • Kawaguchi, Takahisa
  • Kember, Rachel L.|||0000-0001-8820-2659
  • Kentistou, Katherine A.|||0000-0002-5816-664X
  • Kim, Hanna
  • Kim, Young-jin
  • Kleber, Marcus Edi
  • Knol, Maria J.|||0000-0002-3597-1531
  • Kurbasic, Azra
  • Lauzon, Marie
  • Le, Phuong
  • Lea, Rodney A.
  • Lee, Jongyoung
  • Leonard, Hampton L.|||0000-0003-2390-8110
  • Li, Shengchao Alfred
  • Li, Xiaoyin
  • Liang, Jingjing
  • Lin, Honghuang
  • Lin, Shihyi
  • Liu, Jun|||0000-0001-5288-3042
  • Liu, Xueping
  • Lo, Ken Sin
  • Long, Jirong
  • Lores-Motta, Laura
  • Luan, Jian'fan N. An
  • Lyssenko, Valeriya
  • Lyytikäinen, Leo Pekka
  • Mahajan, Anubha|||0000-0001-5585-3420
  • Mamakou, Vasiliki
  • Mangino, Massimo
  • Manichaikul, Ani W.
  • Marten, Jonathan|||0000-0001-6916-2014
  • Mattheisen, Manuel|||0000-0002-8442-493X
  • Mavarani, Laven
  • McDaid, Aaron F.
  • Meidtner, Karina
  • Melendez, Tori L.
  • Mercader, Josep M.|||0000-0001-8494-3660
  • Milaneschi, Yuri|||0000-0002-3697-6617
  • Miller, Jason E.
  • Millwood, Iona Y.
  • Mishra, Pashupati P.|||0000-0001-5177-3431
  • Mitchell, Ruth E.
  • Møllehave, Line Tang|||0000-0001-7116-9346
  • Morgan, Anna
  • Mucha, Soeren
  • Munz, Matthias|||0000-0002-4728-3357
  • Nakatochi, Masahiro|||0000-0002-1838-4837
  • Nelson, Christopher P.
  • Nethander, Maria
  • Nho, Chu Won
  • Nielsen, Aneta A.
  • Nolte, Ilja M.|||0000-0001-5047-4077
  • Nongmaithem, Suraj S.|||0000-0001-5390-0449
  • Noordam, Raymond|||0000-0001-7801-809X
  • Ntalla, Ioanna
  • Nutile, Teresa
  • Pandit, Anita
  • Christofidou, Paraskevi
  • Pärna, Katri
  • Pauper, Marc
  • Petersen, Eva R.B.
  • Petersen, Liselotte V.
  • Pitkänen, Niina
  • Polašek, Ozren
  • Poveda, Alaitz|||0000-0001-6349-3955
  • Preuss, Michael H.
  • Pyarajan, Saiju
  • Raffield, Laura M.
  • Rakugi, Hiromi
  • Ramirez, Julia
  • Rasheed, Asif
  • Raven, Dennis
  • Rayner, Nigel W.
  • Riveros, Carlos
  • Rohde, Rebecca
  • Ruggiero, Daniela|||0000-0003-3898-7827
  • Ruotsalainen, Sanni E.|||0000-0002-1631-4069
  • Ryan, Kathleen A.
  • Sabater-Lleal, Maria|||0000-0002-0128-379X
  • Saxena, Richa
  • Scholz, Markus|||0000-0002-4059-1779
  • Sendamarai, Anoop
  • Shen, Botong
  • Shi, Jingchunzi
  • Shin, J.H.
  • Sidore, Carlo|||0000-0001-7504-7477
  • Sitlani, Collen M.|||0000-0001-7656-7482
  • Slieker, Roderick C.
  • Smit, Roelof A. J.
  • Smith, Albert V.
  • Smith, Jennifer A.|||0000-0002-3575-5468
  • Smyth, Laura J.|||0000-0001-6419-4826
  • Southam, Lorraine
  • Steinthorsdottir, Valgerdur
  • Sun, Liang
  • Takeuchi, Fumihiko
  • Tallapragada, Divya Sri Priyanka
  • Taylor, Kent|||0000-0002-2756-4370
  • Tayo, Bamidele O.
  • Tcheandjieu, Catherine
  • Terzikhan, Natalie
  • Tesolin, Paola|||0000-0002-5238-6422
  • Teumer, Alexander|||0000-0002-8309-094X
  • Theusch, Elizabeth|||0000-0002-5678-759X
  • Thompson, Deborah J.
  • Thorleifsson, Gudmar|||0000-0003-4623-9087
  • Timmers, Paul R. H. J.
  • Trompet, Stella|||0000-0001-5006-0528
  • Turman, Constance
  • Vaccargiu, Simona
  • van der Laan, Sander W.|||0000-0001-6888-1404
  • van der Most, Peter J.|||0000-0001-8450-3518
  • van Klinken, Jan Bert
  • van Setten, Jessica A.
  • Verma, Shefali Setia
  • Verweij, Niek|||0000-0002-4303-7685
  • Veturi, Yogasudha C.
  • Wang, Carol A.|||0000-0002-4301-3974
  • Wang, Chaolong
  • Wang, Lihua
  • Wang, Zhe|||0000-0003-0786-9887
  • Warren, Helen R.
  • Bin Wei, Wen
  • Wickremasinghe, Ananda|||0000-0002-6174-6784
  • Wielscher, Matthias|||0000-0003-4138-1383
  • Wiggins, Kerri L.|||0000-0003-2749-1279
  • Winsvold, Bendik Slagsvold|||0000-0003-4171-8919
  • Wong, Andrew|||0000-0003-2079-4779
  • Wu, Yang|||0000-0002-0128-7280
  • Wuttke, Matthias|||0000-0003-3420-5082
  • Xia, Rui|||0000-0003-2409-1181
  • Xie, Tian
  • Yamamoto, Ken
  • Yang, Jingyun
  • Yao, Jie
  • Young, Hannah|||0000-0002-4248-9612
  • Yousri, Noha A.|||0000-0003-1918-0331
  • Yu, Lei
  • Zeng, Lingyao
  • Zhang, Weihua
  • Zhang, Xinyuan
  • Zhao, Jinghua
  • Zhao, Wei|||0000-0002-4839-6791
  • Zhou, Wei
  • Zimmermann, Martina E.|||0000-0002-6916-4404
  • Zoledziewska, Magdalena|||0000-0002-3033-6133
  • Adair, Linda S.
  • Adams, Hieab H. H.|||0000-0003-3687-2508
  • Aguilar-Salinas, Carlos Alberto
  • Al-Mulla, Fahd|||0000-0001-5409-3829
  • Arnett, Donna|||0000-0003-2219-657X
  • Asselbergs, Folkert W.|||0000-0002-1692-8669
  • Åsvold, Bjørn Olav|||0000-0003-3837-2101
  • Attia, John Richard
  • Banas, Bernhard|||0000-0003-2076-2195
  • Bandinelli, Stefania|||0000-0002-6491-0850
  • Bennett, David Alan
  • Bergler, Tobias
  • Bharadwaj, Dwaipayan
  • Biino, Ginevra|||0000-0002-9936-946X
  • Bisgaard, Hans
  • Boerwinkle, Eric|||0000-0001-8813-0544
  • Böger, Carsten A.
  • Bønnelykke, Klaus
  • Boomsma, Dorret I.|||0000-0002-7099-7972
  • Børglum, Anders D.|||0000-0001-8627-7219
  • Borja, Judith B.
  • Bouchard, Claude|||0000-0002-0048-491X
  • Bowden, Donald W.
  • Brandslund, Ivan
  • Brumpton, Ben
  • Buring, Julie E.
  • Caulfield, Mark|||0000-0001-9295-3594
  • Chambers, John C.
  • Chandak, Giriraj R.
  • Chanock, Stephen|||0000-0002-2324-3393
  • Chaturvedi, Nish
  • Chen, Yii Der Ida
  • Chen, Zhengming|||0000-0001-6423-105X
  • Cheng, Ching-Yu|||0000-0003-0655-885X
  • Christophersen, Ingrid E.
  • Ciullo, Marina|||0000-0002-9621-9984
  • Cole, John W.|||0000-0001-9263-8930
  • Collins, Francis S.|||0000-0002-1023-7410
  • Cooper, Richard S.
  • Cruz, Miguel
  • Cucca, Francesco|||0000-0002-7414-1995
  • Cupples, L. Adrienne
  • Cutler, Michael J.
  • Damrauer, Scott M.|||0000-0001-8009-1632
  • Dantoft, Thomas M.
  • de Borst, Gert J.
  • de Groot, Lisette C.P.G.M.|||0000-0003-2778-2789
  • De Jager, Philip L.|||0000-0002-8057-2505
  • de Kleijn, D.P.V.|||0000-0003-2714-2140
  • Janaka de Silva, H.
  • Dedoussis, George V.
  • den Hollander, Anneke I.
  • Du, Shufa
  • Easton, Douglas F.|||0000-0003-2444-3247
  • Elders, Petra J. M.
  • Eliassen, A. Heather Heather
  • Ellinor, Patrick T.
  • Elmståhl, Sölve
  • Erdmann, Jeanette|||0000-0002-4486-6231
  • Evans, Michele K.
  • Fatkin, Diane
  • Feenstra, Bjarke|||0000-0003-1478-649X
  • Feitosa, Mary|||0000-0002-0933-2410
  • Ferrucci, Luigi
  • Ford, Ian
  • Fornage, Myriam|||0000-0003-0677-8158
  • Franke, Andre|||0000-0003-1530-5811
  • Franks, Paul W.|||0000-0002-0520-7604
  • Freedman, Barry I.|||0000-0003-0275-5530
  • Gasparini, Paolo
  • Gieger, Christian|||0000-0001-6986-9554
  • Girotto, Giorgia|||0000-0003-4507-6589
  • Goddard, Michael E.
  • Golightly, Yvonne M.
  • Gonzalez-Villalpando, Clicerio
  • Gordon-Larsen, P.
  • Grallert, H.
  • Grant, Struan F. A.|||0000-0003-2025-5302
  • Grarup, Niels|||0000-0001-5526-1070
  • Griffiths, L.
  • Gudnason, V.
  • Haiman, C.
  • Hakonarson, Hakon|||0000-0003-2814-7461
  • Hansen, Torben|||0000-0001-8748-3831
  • Hartman, C.A.
  • Hattersley, A.T.
  • Hayward, Caroline|||0000-0002-9405-9550
  • Heckbert, S.R.
  • Heng, C.K.
  • Hengstenberg, C.
  • Hewitt, Alex W.|||0000-0002-5123-5999
  • Hishigaki, H.
  • Hoyng, C.B.
  • Huang, Paul L.
  • Huang, W.
  • Hunt, S.C.
  • Hveem, K.
  • Hyppönen, E.
  • Iacono, William
  • Ichihara, S.
  • Ikram, M.A.
  • Isasi, C.R.
  • Jackson, R.D.
  • Jarvelin, Marjo-Riitta|||0000-0002-2149-0630
  • Jin, Zi-Bing
  • Jöckel, K.H.
  • Joshi, P.K.
  • Jousilahti, P.
  • Jukema, J.W.
  • Kähönen, M.
  • Kamatani, Yoichiro|||0000-0001-8748-5597
  • Kang, K.D.
  • Kaprio, Jaakko|||0000-0002-3716-2455
  • Kardia, S.L.R.
  • Karpe, F.
  • Kato, N.
  • Kee, F.
  • Kessler, T.
  • Khera, Amit V.
  • Khor, C.C.
  • Kiemeney, Lambertus A.
  • Kim, B.J.
  • Kim, E.K.
  • Kim, H.L.
  • Kirchhof, P.
  • Kivimaki, Mika|||0000-0002-4699-5627
  • Koh, W.P.
  • Koistinen, H.A.
  • Kolovou, G.D.
  • Kooner, J.S.
  • Kooperberg, C.
  • Köttgen, A.
  • Kovacs, P.
  • Kraaijeveld, A.
  • Kraft, Peter
  • Krauss, R.M.
  • Kumari, M.
  • Kutalik, Zoltan|||0000-0001-8285-7523
  • Laakso, Markku|||0000-0002-3394-7749
  • Lange, Leslie A.
  • Langenberg, C.
  • Launer, L.J.
  • Le Marchand, L.
  • Lee, H.
  • Lee, N.R.
  • Lehtimäki, T.
  • Li, H.
  • Li, L.
  • Lieb, Wolfgang|||0000-0003-2544-4460
  • Lin, X.
  • Lind, Lars
  • Linneberg, Allan|||0000-0002-0994-0184
  • Liu, Ching-Ti
  • Liu, Jianjun|||0000-0002-3255-3019
  • Loeffler, Markus
  • London, Barry
  • Lubitz, Steven A.
  • Lye, Stephen J.
  • Mackey, David A.
  • Mägi, Reedik
  • Magnusson, Patrik K. E.|||0000-0002-7315-7899
  • Marcus, Gregory M.|||0000-0001-5197-7696
  • Vidal, Pedro M.
  • Martin, Nicholas G.|||0000-0003-4069-8020
  • März, Winfried|||0000-0001-6083-8946
  • Matsuda, Fumihiko
  • McGarrah, Robert W.
  • McGue, Matt|||0000-0002-5580-1433
  • McKnight, Amy Jayne|||0000-0002-7482-709X
  • Medland, Sarah Elizabeth|||0000-0003-1382-380X
  • Mellström, Dan|||0000-0003-2761-3723
  • Metspalu, Andres|||0000-0002-3718-796X
  • Mitchell, Braxton|||0000-0003-4920-4744
  • Mitchell, Paul
  • Mook-Kanamori, Dennis O.
  • Morris, Andrew D.
  • Mucci, Lorelei A.
  • Munroe, Patricia B.|||0000-0002-4176-2947
  • Nalls, Mike A.
  • Nazarian, Saman
  • Nelson, Amanda E.
  • Neville, Matt J.|||0000-0002-6004-5433
  • Newton-Cheh, Christopher
  • Nielsen, Christopher S.
  • Nöthen, Markus M.|||0000-0002-8770-2464
  • Ohlsson, Claes|||0000-0002-9633-2805
  • Oldehinkel, Albertine J.|||0000-0003-3925-3913
  • Orozco, Lorena|||0000-0002-5801-9180
  • Pahkala, Katja
  • Pajukanta, Päivi
  • Palmer, Colin N. A.
  • Parra, Esteban J.|||0000-0002-2057-8577
  • Pattaro, Cristian|||0000-0002-4119-0109
  • Pedersen, Oluf
  • Pennell, Craig E.|||0000-0002-0937-6165
  • Penninx, Brenda W. J. H.
  • Pérusse, Louis|||0000-0001-6440-9698
  • Peters, Annette|||0000-0001-6645-0985
  • Peyser, Patricia A.
  • Porteous, David J.|||0000-0003-1249-6106
  • Posthuma, Danielle|||0000-0001-7582-2365
  • Power, Chris
  • Pramstaller, Peter P.
  • Province, Michael A.|||0000-0001-6102-774X
  • Qi, Qibin
  • Qu, Jia
  • Rader, Daniel J.
  • Raitakari, Olli T.
  • Ralhan, Sarju
  • Rallidis, Loukianos S.
  • Rao, Dabeeru C.
  • Redline, Susan
  • Reilly, Dermot F.
  • Reiner, Alexander P.
  • Rhee, Sang Youl|||0000-0003-0119-5818
  • Ridker, Paul M.
  • Rienstra, Michiel|||0000-0002-2581-070X
  • Ripatti, Samuli|||0000-0002-0504-1202
  • Ritchie, Marylyn D.|||0000-0002-1208-1720
  • Roden, Dan M.
  • Rosendaal, Frits|||0000-0003-2558-7496
  • Rotter, Jerome I.|||0000-0001-7191-1723
  • Rudan, Igor|||0000-0001-6993-6884
  • Rutters, Femke
  • Sabanayagam, Charumathi|||0000-0002-4042-4719
  • Saleheen, Danish|||0000-0001-6193-020X
  • Salomaa, Veikko|||0000-0001-7563-5324
  • Samani, Nilesh J.
  • Sanghera, Dharambir K.
  • Sattar, Naveed|||0000-0002-1604-2593
  • Schmidt, Börge
  • Schmidt, Helena|||0000-0001-9773-9992
  • Schmidt, Reinhold
  • Schulze, Matthias B.
  • Schunkert, Heribert|||0000-0001-6428-3001
  • Scott, Laura J.|||0000-0002-4886-5084
  • Scott, Rodney J.|||0000-0001-7724-3404
  • Sever, Peter
  • Shiroma, Eric J.
  • Shoemaker, M. Benjamin
  • Shu, Xiao-Ou
  • Simonsick, Eleanor M.
  • Sims, Mario
  • Singh, Jai Rup
  • Singleton, Andrew B.|||0000-0001-5606-700X
  • Sinner, Moritz F.
  • Smith, J. Gustav
  • Snieder, Harold|||0000-0003-1949-2298
  • Spector, Tim|||0000-0002-9795-0365
  • Stampfer, Meir J.
  • Stark, Klaus J.
  • Strachan, David P.
  • 't Hart, Leen M.
  • Tabara, Yasuharu
  • Tang, Hua
  • Tardif, J.C.
  • Thanaraj, T.A.
  • Timpson, N.J.
  • Tönjes, A.
  • Tremblay, A.
  • Tuomi, T.
  • Tuomilehto, J.
  • Tusié-Luna, M.T.
  • Uitterlinden, André G.|||0000-0002-7276-3387
  • van Dam, Rob M.
  • van der Harst, Pim|||0000-0002-2713-686X
  • Van der Velde, Nathalie
  • van Duijn, Cornelia M.|||0000-0002-2374-9204
  • van Schoor, N.M.
  • Vitart, Veronique|||0000-0002-4991-3797
  • Völker, U.
  • Vollenweider, P.
  • Völzke, Henry|||0000-0001-7003-399X
  • Wacher-Rodarte, N.H.
  • Walker, M.
  • Wang, Y.X.
  • Wareham, N.J.
  • Watanabe, R.M.
  • Watkins, Hugh
  • Weir, D.R.
  • Werge, Thomas M.
  • Widen, E.
  • Wilkens, Lynne R.
  • Willemsen, Gonneke|||0000-0003-3755-0236
  • Willett, Walter C.
  • Wilson, James F.|||0000-0001-5751-9178
  • Wong, Tien-Yin
  • Woo, Jeong-Taek|||0000-0001-9201-0713
  • Wright, Alan F.
  • Wu, Jer-Yuarn
  • Xu, Huichun|||0000-0001-8118-9607
  • Yajnik, Chittaranjan S.
  • Yokota, Mitsuhiro
  • Yuan, Jian-Min|||0000-0002-4620-3108
  • Zeggini, Eleftheria|||0000-0003-4238-659X
  • Zemel, Babette S.
  • Zheng, Wei|||0000-0003-1226-070X
  • Zhu, X.|||0000-0003-0037-411X
  • Zmuda, Joseph M.
  • Zonderman, Alan B.|||0000-0002-6523-4778
  • Zwart, John-Anker|||0000-0001-5721-0154
  • Croteau-Chonka, Damien
  • Vonk, Judith M.
  • Le Marchand, Loic
  • Chasman, Daniel I.|||0000-0003-3357-0862
  • Cho, Yoon Shin
  • Heid, Iris M.
  • McCarthy, Mark I.
  • Ng, Maggie C. Y.
  • O'Donnell, Christopher J.
  • Rivadeneira, Fernando|||0000-0001-9435-9441
  • Thorsteinsdottir, Unnur
  • Sun, Yan V.|||0000-0002-2838-1824
  • Tai, E. Shyong
  • Boehnke, Michael|||0000-0002-6442-7754
  • Deloukas, Panos|||0000-0001-9251-070X
  • Justice, Anne E.
  • Lindgren, Cecilia M.
  • Loos, Ruth J. F.|||0000-0002-8532-5087
  • Mohlke, Karen L.|||0000-0001-6721-153X
  • North, Kari E.
  • Stefánsson, Kári|||0000-0003-1676-864X
  • Walters, Robin G.|||0000-0002-9179-0321
  • Winkler, Thomas W.|||0000-0003-0292-5421
  • Young, Kristin L.|||0000-0003-0070-6145
  • Loh, Po-Ru
  • Yang, Jian|||0000-0003-4800-832X
  • Esko, Tõnu
  • Assimes, Themistocles|||0000-0003-2349-0009
  • Auton, Adam
  • Abecasis, Goncalo
  • Willer, Cristen J.|||0000-0001-5645-4966
  • Locke, Adam E.|||0000-0001-6227-198X
  • Berndt, Sonja
  • Lettre, Guillaume
  • Frayling, Timothy M.
  • Okada, Yukinori|||0000-0002-0311-8472
  • Wood, Andrew R.|||0000-0003-1726-948X
  • Visscher, PM.|||0000-0002-2143-8760
  • Hirschhorn, Joel N.|||0000-0002-1650-7901
Common single-nucleotide polymorphisms (SNPs) are predicted to collectively explain 40-50% of phenotypic variation in human height, but identifying the specific variants and associated regions requires huge sample sizes. Here, using data from a genome-wide association study of 5.4 million individuals of diverse ancestries, we show that 12,111 independent SNPs that are significantly associated with height account for nearly all of the common SNP-based heritability. These SNPs are clustered within 7,209 non-overlapping genomic segments with a mean size of around 90 kb, covering about 21% of the genome. The density of independent associations varies across the genome and the regions of increased density are enriched for biologically relevant genes. In out-of-sample estimation and prediction, the 12,111 SNPs (or all SNPs in the HapMap 3 panel) account for 40% (45%) of phenotypic variance in populations of European ancestry but only around 10-20% (14-24%) in populations of other ancestries. Effect sizes, associated regions and gene prioritization are similar across ancestries, indicating that reduced prediction accuracy is likely to be explained by linkage disequilibrium and differences in allele frequency within associated regions. Finally, we show that the relevant biological pathways are detectable with smaller sample sizes than are needed to implicate causal genes and variants. Overall, this study provides a comprehensive map of specific genomic regions that contain the vast majority of common height-associated variants. Although this map is saturated for populations of European ancestry, further research is needed to achieve equivalent saturation in other ancestries.